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SECTION 1: INTRODUCTION 
1.1. Background and context of the study 
Organ regeneration in mammals is hypothesized to require a functional pool of stem or 
progenitor cells which have the capacity to replace damage cells or tissues [1, 2]. But, the 
role of these cells in lung regeneration is still unclear [3, 4]. A better understanding of the 
contribution of lung stem cells in repair and regeneration is imperative to provide an 
insight to lung diseases. Chronic diseases like cancer, Chronic Obstructive Pulmonary 
Disease (COPD) and Bronchopulmonary Dysplasia (BPD) remain an important cause of 
morbidity and mortality [5, 6]. These diseases imply changes of the cells in the lungs. 
Research on lung stem cells could enlighten the causes of such diseases, and may provide 
approaches for clinical therapies. Lung stem cells may serve as a treatment in future to 
tackle life-threatening respiratory diseases and improve the quality of life/patients 
prognosis. Lung stem cells have mostly been identified and characterized in genetically 
modified mice [7, 8]. In the adult lung, it is well established that there are many sources 
of stem/ progenitor cells. But, it is still unclear which is the most effective in terms of 
lung repair and remodelling [9-12]. The long-term goal for studying stem cells in the adult 
lung will be the development of new therapeutic strategies for causal treatment of 
destructive lung diseases. One way to achieve this goal is to develop new technical 
approaches for the identification of stem cells by identifying markers, and to understand 
their role in normal lung physiology and lung diseases. Indeed, adult stem cells have 
already been utilized for therapies for several years and novel treatments are constantly 
developed. Hematopoietic stem cells and mesenchymal stem cells for example are 
currently evaluated for clinical tests [13, 14].  
 
1.2.  Generalities and characteristics of stem cells 
The vast majority of cells that compose the body are differentiated. They are specialized 
for different functions and thus, they are not capable of generating other cell types [3]. 
Neurons, blood cells, muscles and skin are all made up of mature cells [4]. However, 
there are cells which are undifferentiated, able to divide and have the ability to give rise 
to other cell types. These cells are called stem cells. Stem cells display two main 
characteristics. They are able to create unlimited copies of themselves maintaining the 
same features by cell division; a property known as self-renewal, and to give rise to 
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specialized cell types such as skin cells, muscle cells or neural cells. Living organisms 
rely on this continual mechanism of self-renewal to grow; it is indispensable for the 
replenishment of the body cells after loss or tissue damage during life process [13] [15] 
[16]. During early development, stem cells undergo symmetric cell division. Each stem 
cell give rise to identical daughter cells maintaining the same characteristics including the 
ability to proliferate, to self-renew and to produce daughter cells. Later in the 
development, asymmetric cell division takes place. Stem cells divide to give rise to 
identical daughter cells and to committed progenitor cells that undergo differentiation, 
thereby, providing self-renewal and sustaining tissue homeostasis [17, 18]. Progenitor 
cells also called transient amplifying (TA) cells or precursor cells, undergo asymmetrical 
cell division and produce specialized cells [19]. For instance, epithelial stem cells of 
mouse small intestine produce TA cells that differentiate into various cell types of the 
villi crypts [20]. Stem cells self-renewal and differentiation are regulated by the cell cycle 
to enable the cell fate. In fact, stem cell maintenance is important for homeostasis, 
thereby, cell cycle is necessary for controlling the cell number in organisms [21] [22]. 
Cell cycle is composed of four distinct phases. The gap before DNA synthesis (G1), the 
S phase , the gap after the S phase (G2) and the M phase called mitosis [23]. These four 
phases are devoted to the replication of the chromosomal DNA and to the transmission 
of the genetic material to daughter cells. The G1 phase also called “start” is the first 
checkpoint of the cell cycle. The cells are committed to full cell division cycle [21]. 
During this phase, the cells become bigger and expand. They synthesize molecules such 
as mRNA and proteins which are necessary for DNA synthesis. The cells which undergo 
proliferation and regeneration stay in G1 phase [24]. The G1 phase ends when the cells 
enter the S phase. During the S phase, the cells synthesize DNA and replicate. During 
embryogenesis, most of the cells are in S phase. Loss of pluripotency causes changes in 
the cells and they enter the G1 phase [25]. The G2 phase is the second checkpoint of the 
cell cycle for any problem which have might occurred during the S phase. The cells 
synthesize proteins and prepare for the cell division. Finally, during mitosis, the cells 
divide and give rise to identical daughter cells that enter the G1 phase. The cells that have 
stopped to divide such as nerve cells and skeletal muscle cells enter the G0 phase [21] 
(Fig. 1). 
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Fig. 1 The cell cycle stages of a stem cell 
The cell cycle begins in G1. In G1, the stem cells grow and prepare to enter the S phase. In S phase, the cells 
duplicate their DNA. At this stage, a high proportion of the cells are pluripotent with a very short G1 phase. 
In G2, the cells prepare to inter the M phase (mitosis). During the M phase, the stem cells divide and each 
cell produces two identical daughter cells. One daughter cell enters the G1 phase and the other cell enters 
the G0 phase. In G0, cells are differentiated. At this stage, they can undergo cell death or reenter the G1 
phase. Adapted from department biology: Lund University, Sweden. Source:http://www4.lu.se/cell-
proliferation-group/research/the-role-of-the-polyamines-in-cell-cycle-control-and-program. 
 
1.3. Origin of stem cells 
Once a sperm fertilizes an oocyte, the fertilized egg undergoes several rounds of cell 
division; the cells start to differentiate. At a very early stage of the development, any cell 
can develop into a new individual [26]. These cells are known as totipotent stem cells 
[27]. They have the ability to give rise to specialized tissues or organs such as liver, 
pancreas, blood, brain, skin and cardiac muscle [28, 29]. This ability to give rise to all 
cell types is a common property of the fertilized oocyte and early embryonic cells known 
as developmental plasticity [27, 30, 31]. Sorted in two groups, totipotent stem cells will 
contribute either to the placenta or to embryo formation. Actually, the primary four-celled 
embryo undergoes cell division and becomes a hollow ball called blastocyst [32]. The 
outer cell layer of the blastocyst is only composed of cdx2-expressing cells which build 
the trophoblast. The inner cell mass (ICM) is composed of Oct3/4-expressing cells which 
compose the embryo and have the ability to differentiate [33]. In the ICM, these cells are 
known as pluripotent embryonic stem cells (ESCs) [27] [34]. Pluripotent ESCs are similar 
to totipotent stem cells in that they can differentiate into all the tissue types of the 
organism; however, they cannot produce a new individual because they cannot form 
extra-embryonic tissues or placenta. These ESCs generate the body plan. During 
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development, many cells die and need to be replaced. This is carried out by multipotent 
stem cells. They reside in developed tissues, leading their growth and maintenance 
through life processes. For example, hematopoietic stem cells are able to produce 
progenitors to all blood cells types which need to be replaced regularly [35]. Unipotent 
stem cells which originate from multipotent stem cells produce specific stem cells. Skin 
cells, which are in the epithelium, are one of the most abundant source of unipotent stem 
cells including bulge stem cells or interfollicular epidermis [36, 37] (Fig. 2). 
 
 
Fig. 2 Origin of stem cells. 
A fertilized egg divides and develops into a blastocyst (totipotent stem cells). The inner 
cell mass of the blastocyst forms the embryo (pluripotent stem cells). The embryo give 
rise to the three primary germs layers: ectoderm, mesoderm, and endoderm (multipotent 
stem cells) that give rise to all the cell types of the body. Source: wikipedia. Modified 
from Blastocyst.png 2007. 
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1.4. Different types of stem cells 
Generally, there are two main types of stem cells. Embryonic stem cells (ESCs) which 
are the cells found in embryo and adult stem cells also called somatic stem cells of which 
the origin is still unclear [27, 36]. 
 
1.4.1. Embryonic stem cells 
ESCs originate from the inner cell mass of the blastocyst and they are mostly 
characterized by their ability to regenerate indefinitely in culture and keeping their 
undifferentiated state [27, 38, 39]. Their capacity to remain undifferentiated has been 
studied in vitro through avian ESCs where it has been shown that they were able to be 
maintained for long-term in culture [40]. Many human ESCs lines have also been reported 
to proliferate indefinitely in vitro [41]. ESCs can differentiate into the three primitive 
germ layers; ectoderm, mesoderm and endoderm which develop into specialized tissues 
and organs (Fig. 2). The ectoderm develops into the skin (epidermis), brain and neural 
cells [42]. The mesoderm develops into the skeleton, the muscles, the circulatory system, 
skin (dermis). The mesoderm which covers the surface of the lungs develops into the 
visceral pleura and the somatic mesoderm which covers the body wall from the inside, 
develops into the parietal pleura. The endoderm develops into the respiratory system and 
the gastrointestinal system [43] [44]. 
 
1.4.2. Adult stem cells  
While ESCs are defined by their origin as the cells found in embryo, the origin of adult 
stem cells is still unclear [27]. The term “adult stem cell” refers to the fact that those cells 
are found in postnatal tissues. They are present in infants, children and as well as in adults. 
Investigators use also the term “somatic stem cell” as it means cell of the body, to describe 
an adult stem cell. Adult stem cells are found in many tissues and organs including brain 
[45], skin [46],  pancreas [47], bone marrow [48], liver [49], lung [3] and skeletal muscles 
[50] [51]. For instance, (i)-the stem cells in brain can generate different types of neural 
tissues including astrocytes and neurons. (ii)- Hematopoietic stems cells which reside in 
the bone marrow have the ability to generate all the blood cells types. (iii)- Following 
injury, hepatocytes which are normal liver cells, can reenter the cell cycle division to 
repair the tissues [27, 52]. 
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1.5. Adult lung stem cells  
Adult lung stem cells include mesenchymal and epithelial stem cells. Mesenchymal stem 
cells (MSCs) are multipotent stem cells and they can give rise to different cell types such 
as chondroblasts, osteoblasts, endothelial, perivascular cells and adipocytes [53, 54] [55] 
[56]. They were isolated for the first time in 1970 from the bone marrow and spleen 
suspensions [57]. They have been since then identified in many organs including lungs. 
They are able to proliferate and differentiate into fibroblasts, myofibroblasts and probably 
into lipofibroblats [56] [58]. The real function of MSCs is not well understood yet in 
different organs except the fact that they represent a microenvironment for the 
hematopoietic stem cells niche [59]. Moreover, in the lungs they have been shown to 
stimulate for instance, the growth of bronchioalveolar stem cells (BASCs) when they 
were seeded in co-culture growth conditions/experiments [60]. In addition, they have also 
been shown to contribute to lung repair after injury in mouse model of Bronchopulmonary 
Dysplasia [61] and in vitro in wound healing assay in alveolar type 2 cells [62]. Epithelial 
cells, which cover the entire surface of the airways also contain different types of cells 
which have been involved in lung repair and regeneration. From the upper to the lower 
airway regions, the epithelium harbors various stem cell niches whose cells are able to 
self-renew, proliferate and regenerate the tissue during the normal turnover or after tissue 
damages [63] . Basal cells, Clara cells or BASCs for instance have been proved to 
participate to these mechanisms by using animal models for lineage tracing and injuries 
[11, 12, 64-66]. 
 
1.6. Lung epithelial stem cells niches and their contribution in adult lung 
The lung consists of two main regions (Fig. 3). The upper part composed of the trachea, 
the two main bronchi and the bronchioles represents the conducting airway part. The 
second part composed of alveoli give rise to the site of the gas exchange surface. In the 
upper airways, the epithelium is pseudostratified and columnar and is mostly made up of 
goblet cells, basal cells and submucosal glandular epithelium. In the lower airways, 
meaning the bronchioles where the epithelium is cuboidal, Clara cells are predominantly 
expressed compared to the ciliated cells and neuroendocrine cells. In distal alveolar space, 
the epithelium is squamous and contains alveolar type 1 and type 2 cells. Alveolar type 1 
cells are indeed less abundant than type 2 cells but they line 95 % of the alveolar surface 
by forming a thin flat squamous cell layer [67] . This complex anatomy of the lung is 
indeed reflected by various stem cell niches present at different anatomical levels [68] 
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(Fig.3). The study of lineage tracing and models of injury in the mouse lung have 
suggested that epithelial repair and regeneration is sustained by different stem/progenitor 
cells which dwell in particular microenvironments through the upper-lower airway 
regions [67]. Basal cells in trachea show stem/progenitor cell characteristics. For instance, 
it has been shown that after injury, keratin-14-expressing basal cells were able to 
replenish the trachea [65]. Clara cells are thought to be the progenitors of other Clara and 
ciliated cells. Rawlins et al [11] showed by lineage tracing that Sgb1a1-expressing Clara 
cells generate both ciliated cells and Clara cells in the trachea. Furthermore, they could 
contribute to tracheal repair with low potential of self-renewal, but not to the alveolar 
epithelium repair. Alveolar type 2 cells as well show stem cell capacity; they renew 
themselves and alveolar type 1 cells as reported in recent studies [69] . BASCs called also 
variant Clara cells of the bronchiolar–alveolar duct junction (BADJ) appear to regenerate 
both the bronchioles and the proximal alveolar region [12]. More recently, 
CD45negCD31negEpCAMhighCD24low cell population exhibiting stem cell properties has 
been described as epithelial stem/progenitor cells (ESPCs) in adult mouse lung [70]. 
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Fig. 3 Architecture of the lung and epithelial stem cells niches.  
The circled areas represent the different stem cell niches described in adult mouse lung and the 
discontinuous lines represent the cells which reside in these microenvironments. Modified from 
Expert Rev Resp Med. 2008;2(3):365-380. 
 
1.7. Bronchioalveolar stem cells and their contribution in  adult lung 
BASCs, which are present at the duct junction between the terminal bronchioles and the 
alveolar space have the potential to contribute substantially to the lung repair and 
regeneration [71]. They were described in mice to have many of the properties expected 
of stem cells that they could contribute to the regeneration of terminal bronchioles and 
their associated alveoli. They are co-stained for CCSP (Clara cell secretory protein) and 
SPC (surfactant protein C), markers of Clara cells found in the bronchioles and alveolar 
type 2 cells respectively [12]. Based on the Sca-1posCD34pos cell fraction, BASCs were 
cloned and passaged on feeder cells and shown to differentiate to Clara-like cells and 
alveolar type 2-like cells in vitro. However, others studies performed in adult mouse lung 
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indicate that the Sca-1pos cell fraction is predominantly representative of mesenchymal 
cell lineages [70]. This highlights that Sca-1 is not a selectable marker for epithelial stem 
cells in the adult murine lung. Several questions remain to generalize BASCs as stem 
cells for distal components of the airways and the lung parenchyma [72]. First, they have 
only been tested in the bleomycin, a model of lung damage, which is more a model of 
fibrosis than true damage and regeneration. They proved resistance to naphthalene that 
damage bronchiolar epithelium [10]. Not only BASCs survive to these treatments. In 
summary, the evidence that BASCs serve as a real stem cells is highly challenged, 
therefore the alternative functional assays are clearly needed for the identification and 
characterization of BASCs. 
 
1.8. New approaches for the characterization of BACS  
Harold A. Chapman et al. [73] were able to demonstrate that embryonic lung cells 
transplanted under the kidney capsule of an immunodeficient mouse were able to grow 
into structures which resemble the lungs with branching and alveolar spaces. This model 
mimics the lung structure and was proven to be relevant for cell fate mapping and as well 
as to validate their regenerative ability. Therefore this model can be used as an alternative 
method to identify BASCs and to confirm their regenerative potential in vivo. In vitro, 
there are no novel studies which address BASCs as putative stem cells. Recent published 
studies described a small population of epithelial cells which is 
CD45negCD31negEpCAMhighCD24low as epithelial stem/progenitor cells (ESPCs) whose 
descendants give rise to all the epithelial cell lineages in adult mouse lung. This 
population represents around 1 % of the total epithelial cell population and has the 
capacity to self-renew and generate different types of epithelial colonies in vitro 
including, MUC5AC-expressing colonies, CCSP-expressing colonies and alveolar type-
2- expressing colonies which were observed in matrigel cultures [70]. However, they did 
not show any relation of EpCAMhighCD24low to BASCs. This observation raised the 
hypothesis that BASCs as stem cells may then be included in the EpCAMhighCD24low cell 
fraction. On this basis, our strategy was to demonstrate whether EpCAMhighCD24low cell 
fraction contained BASCs and to test also whether BASCs could grow into colonies. For 
these experiments, wild type mice were used. In addition, double-fluorescent Cre reporter 
mice expressing YFP and mCherry under the control of SPC and CCSP promoters were 
used for follow-up studies to find out whether they will conform to initial clonogenic 
studies. 
Section 1: Introduction 
18 
1.9. Oct4 positive cells: a novel subset of putative mesenchymal stem cells in adult 
lung 
 
1.9.1.  Generalities  
The study of lung stem cells is mostly understood by using genetically engineered mice 
and lung disease models. This contributes indeed, to the identification of stem cell 
populations by mean of different stem cell markers [3] such as stem cell antigen 1 (Sca-
1) , Clara cell secretory protein (CCSP), CD34 and Octamer-4 (Oct4) [74]. It has been 
reported that Oct4 is expressed in postnatal mouse pulmonary cells infected with SARS 
coronavirus [74]. In this context, Oct4 can also be used as a stem cell descriptor for lung 
adult stem cells. Actually, a role for maintaining pluripotency and self-renewal of ESCs 
is ascribed to Oct4 as a marker of pluripotency [75]. Specially expressed in ESCs, Oct4 
can also be detected in adult stem cells such as bone marrow-derived mesenchymal stem 
cells. As a matter of fact, several studies suggest a role for Oct4 in sustaining self-renewal 
capacity of adult somatic stem cells [76]. However, there is also evidence that Oct4 gene 
ablation in somatic stem cells revealed no abnormalities in homeostasis or regenerative 
capacity. Data strongly argue that Oct4, even if expressed at low levels in somatic cells, 
is dispensable for the self-renewal of somatic stem cells, for tissue homeostasis, and for 
the regeneration of adult tissues [77]. This is the conclusive scan of Oct4 that it is not a 
key pluripotency regulator in adult stem cells. Moreover, Oct4 was found to be expressed 
in telocytes; in human skeletal muscle cell niche [78]. In mouse lungs, telocytes line the 
perivascular and peribronchial spaces and they extend to the alveolar compartment [79] 
(Fig.3). 
 
1.9.2. Telocytes: a novel interstitial-stromal cell type of mesenchymal origin 
Telocytes are a novel described interstitial (stromal) cell type in the stem cell field 
showing particular features, with long extensions up to 100 µm called telopodes [80]. 
These telopodes are self-organized in thin fragments called podomers and more enlarged 
fragments called podoms. The telocytes form a 3-dimensional network with intercellular 
junctions [79]. They were discovered in 2005 by Laurențiu M. Popescu's group from 
Bucarest, Romania. They described these cells in various organs including pleura, 
epicardium, myocardium, endocardium, intestine, uterus, pancreas, mammary gland and 
in several others organs [81] [82-86]. They were first named interstitial Cajal-like cells 
(ICLC) [87] [88-91]. For the short story, more than 100 years ago, Ramón y Cajal 
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described a particular cell type that was named interstitial neurons because they 
resembled nerve cells [92]. At the early 1970s, these cells were investigated by electron 
microscopy (EM) and it became obvious that they were not neurons and they were 
therefore renamed interstitial Cajal cells (ICC) [93] [94]. The studies of ICC for the ten 
past years revealed that those cells were similar to ICLC [88-91]. Moreover, the EM 
studies showed that ICLC had particular features which discriminate them from ICC or 
other interstitial cell types like fibrocytes or fibroblasts. They presented different 
ultrastructure and phenotype than ICC; very long extensions with a monoliform shape (a 
form resembling a string of beads). The definitive survey of ICLC was that there were 
not ICC and thus, they proposed to rename those cells telocytes, and telopodes for their 
prolongations [95]. They express different markers in different organs including CD34, 
αSMA, Sca-1, PDGFR-b, S-100, C-kit, vimentin and VEGF in human epicardium, human 
term placenta or skeletal muscle cell niche [78]. Telocytes are cells of mesenchymal 
origin based on their expression markers (c-kit, vimentin, PDGFR-b ) and their 
similarities to ICC which were confirmed to be also from mesenchymal source [96]. A 
role of telocytes in inter-cellular signaling via paracrine secretion as well as by shed 
vesicles and exosomes has been suggested due to their distinguished architecture with 
thin and long telopodes [97]. Their presence in microenvironment of stem cell niches as 
well as the expression of stem cell markers suggests a role in regeneration of tissues [78, 
98]. They have recently been identified in human and mouse terminal and respiratory 
bronchioles as well as in the alveolar ducts [79]  (Fig. 4). 
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Fig. 4 Identification of telocytes in adult mouse lung tissues.  
(A) Telocytes in the perivascular space (black arrows). (B) Telocytes in alveolar duct between the 
respiratory bronchioles and the adjacent alveoli. (C) Telocytes in the peribronchial space at the 
terminal bronchiole. (D) Telocyte in the peribronchial space at the respiratory bronchiole. TC: 
telocyte; Tp: telopode. Source: Max-Planck-Institut for Heart and Lung Research. The pictures were 
kindly provided by PD. Dr. Sawa Kostin. 
 
1.10. Identification and characterization of Oct4 positive cells in adult mouse 
lung 
Transgenic animals are nice tools to monitor the activity of a specific gene in cells or in 
tissues. Homozygous Oct4 transgenic mice expressing green fluorescent protein (GFP) 
are known to be especially useful for identifying and isolating mouse germ cells in vivo 
at different stages of the development [99]. The construct used for transgenesis was 
generated at the European Molecular Biology Laboratory (EMBL, Heidelberg, Germany) 
by the research group of Dr. Hans Schöler. Oct4-GFP transgenes have been generated 
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using different regions Oct4 gene promoter to drive expression of GFP, which enable the 
activity of the Oct4 promoter to be monitored in cells and tissues [100]. Therefore, GFP 
can be used as reporter to observe the expression of Oct4 and to target its localization in 
adult lung tissues. These mice can be also very important for the quantification (flow 
cytometry method) and isolation of Oct4 positive cells (cell sorting method) based on 
GFP endogenous fluorescence.  Phenotypical features of Oct4 positive cells with 
telocytes can then be validated by microscopy after isolation. In addition, double 
immunofluorescence against Oct4 and different markers of telocytes can be especially 
useful to study the correlation of Oct4 positive cells to telocytes. Laser capture 
microdissection which consists to isolate specific cells of interest from tissue sections 
with a laser coupled to a microscope can be used to characterize Oct4 positive cells. In 
fact, this method is useful for extracting and purifying DNA or RNA from the cells of 
interest. Therefore, the RNA expression levels of Oct4 and different markers of telocytes 
can be analyzed in order to support immunohistohemical analyses. 
 
1.11. Hypotheses and aims 
Based on previous data which showed that BASCs are stem cells and they are involved 
in mouse lung repair and regeneration, we aimed to elucidate whether BASCs are stem 
cells of the distal mouse lung. This hypothesis was approached using three experimental 
steps (i), identification of BASCs in adult mouse lung tissues. (ii), analysis of their role 
in repair and regeneration using animal models of injury (naphthalene) and compensatory 
lung growth (pneumonectomy) and (iii), characterization of BASCs and 
EpCAMhighCD24low cell fraction in vitro and in vivo using transgenic approaches. Since 
Oct4 represents an important stem cell marker and has been demonstrated to be expressed 
in the lung, Oct4 expression and function should be analyzed in BASCs.
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SECTION 2: MATERIALS AND METHODS 
2.1. Materials  
 
2.1.1. Animals  
The mice used for experiments were adult (> 8 weeks) and from different mouse strains 
(table 1). The CCSP-mCherry/SPC-YFP mice were generated and kindly provided by Dr. 
Marten Szibor; Department of cardiac development MPI Bad Nauheim, director: Prof. 
Dr. Dr. Thomas Braun. They were bred and maintained in our animal facilities and housed 
according to the European Laboratory Animal Welfare Act and Regulations in animal 
housing facility at Max-Planck-Institute for Heart and Lung Research in Bad Nauheim, 
Germany (status of approval: assessment from ethics committee with the permission for 
animal laboratory experimentations; numbers B2/336 and B2/337 Regierungspräsidium 
Darmstadt). All animals were kept at room temperature in a barrier facility with purified 
air, supplied with food and water ad libitum and exposed to a 12:12-hours (h) light-dark 
cycle.  
Mouse strains Genotype  Source  Breeding & 
maintenance 
C57BL/6-Ola Wild-type (WT) Max-Planck (MPI) MPI 
C57BL/6J Oct4GFP Jackson Lab MPI 
BALB/C NOD/SCID Charles River MPI 
BALB/C CCSP-mCherry/SPC-YFP MPI MPI 
Table 1.  Mouse strains used for the experimentations.  
Oct4-GFP: transgenic mice expressing green fluorescent protein (GFP) under the control of Oct4 promoter. 
NOD/SCID: immunodeficient mice with deficient natural killer cells and impaired T and B lymphocytes 
development. CCSP-mCherry/SPC-YFP double transgenic mice are knock in mouse line generated from 
the crossing between single mouse line; Clara cell secretory protein (CCSP) and surfactant protein C (SP-
C) promoter driven-expression of inactive Cre fragments.  The generation of functional CCSP-SPC protein 
is only possible in these double transgenic mice upon co-expression of BASC-defining marker proteins. 
MPI: Max-Planck-Institute Bad Nauheim. 
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2.1.2.  Antibodies 
All antibodies which were used in the present study are shown in the tables 2 and 3. 
Primary antibodies Cat#number Company  Source  Application & 
(targets)   
Dilution (µl) 
Polyclonal pro-SPC AB3786 Millipore  Rabbit  IF, FC  (alveolar  
epithelial type 2 cells) 
1:400 
Polyclonal CC 10 (T - 18 ) sc-9772 Santa-Cruz Goat  IF, FC (bronchiolar 
epithelial Clara cells) 
1:200 
Monclonal Oct3/4 (C-10) sc-5279 Santa-Cruz Mouse  IF,IHC,ICC, WB 
(mesenchymal cells-
telocytes) 
1:50-100 (IF) 
1:1000 (WB) 
monoclonal anti-vimentin C 9080  Sigma Mouse  IF (mesenchymal 
cells-telocytes) 
1:500 
monoclonal α-SMA- Cy3  C6198 Sigma   Mouse  IF (smooth muscle- 
blood vessels) 
1:500 
polyclonal PDGFR-β (958) sc-432  Santa Cruz Rabbit  IF (mesenchymal 
cells-telocytes) 
1:100 
Anti-Mouse Ly-6A/E /Sca-1   553333 BD 
Bioscences 
Rat  IF (mesenchymal 
stem cells-telocytes) 
1:100 
Polyclonal C-kit(C-19) sc-168 Santa Cruz Rabbit  IF (stem cells-
telocytes) 
1:100 
Polyclonal VEGF(A-20) sc-152 Santa Cruz Rabbit  IF (mesenchyme-
telocytes) 
1:100 
Anti-PDGFR –α ab90967 Abcam Rabbit  IF (fibroblasts) 1:100 
DAPI    Nuclear staining 1:1000 
PCNA ( F - 2 ) sc-25280 Santa Cruz Mouse  Proliferation  1:100 
monoclonal anti-β-actin A5316  Sigma Mouse  WB 1:5000 
Anti-mouse  CD45-FITC 11-0451-82 eBioscience Rat FACS 1µl/ 5 million cells 
Anti-mouse  CD 31-FITC 11-0311-81 eBioscience Rat  FACS 1µl/5 million cells 
Anti-mouse  CD45-APC 17-0451-82 eBioscience Rat  FACS 1µl/5 million cells 
Anti-mouse  CD31-APC  eBioscience Rat FACS 1µl/ 5 million cells 
Anti-mouse  EpCAM (CD326) 25-5791-80 eBioscience Rat FACS 1µl/ 5 million cells 
Anti-mouse  CD24 -PE 12-0242 eBioscience Rat FACS 1µl/ 5 million cells 
Anti-mouse  CD-24-PerCP 45.0242-82 eBioscience Rat FACS 1µl/ 5 million cells 
Table 2: List of the primary antibodies.  
IF: Immunofluorescence: IHC: immunohistochemistry; ICC: immunocytochemistry; WB: western blot; 
FC: flow cytometry; PCNA: proliferating-cell-nuclear-antigen; FACS: fluorescence-activated cell sorting. 
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Secondary  antibodies Cat#number Company  Source  Application  Dilution (µl) 
Alexa fluor 488 A11055 Invitrogen  Donkey anti-
goat  
IF, FC 1:500-1000 
Alexa fluor 488 A11001 Invitrogen Goat anti-
mouse 
IF 1:500-1000 
Alexa fluor 555 A21432 Invitrogen Donkey anti-
goat  
IF, FC 1:500-1000 
Alexa fluor 647 A21247 Invitrogen Goat anti-rat IF 1:500-1000 
Alexa fluor 647 A21246 Invitrogen Goat ant-rabbit IF, FC 1:500-1000 
IgG2a Isotyp Control-FITC 11-4321-80 eBioscience Rat  FACS 1µl/ 5 million cells 
IgG2b Isotype Control-PE 12-4031 eBioscience Rat FACS 1µl/ 5 million cells 
IgG1 k  PECy7 25-4301 eBioscience Rat FACS 1µl/ 5 million cells 
IgG1 k  Control PerCP-Cy5.5 45-4301 eBioscience Rat FACS 1µl/ 5 million cells 
IgG2a K Isotype  Control -APC 17-4321 eBioscience Rat FACS 1µl/ 5 million cells 
Table 3: List of the secondary and IgG control antibodies.  
IF: Immunofluorescence: IHC: immunohistochemistry; FC: flow cytometry; FACS: fluorescence-activated 
cell sorting. 
 
2.1.3. Primers used for the real-time quantitative PCR 
All the primers used for the real-time quantitative PCR are summarized in table 4 
Primer names Foward  Reverse  Company  Application 
Oct4 5´-caagttggcgtggagactttgc-3´ 5´-ccccaaggtgatcctcttctgc-
3´ 
Eurofins MWG 
operon 
LCM  (laser 
capture 
microdissection) 
Vimentin  5´-gagatcgccacctacaggaa-3´ 5´-tccatctctggtctcaaccg-3´ Eurofins MWG 
operon 
LCM 
PDGFR-β 5´-agggggcgtgatgactagc-3´ 5´-ttccaggagtgataccagctt-3´ Eurofins MWG 
operon 
LCM 
Sca-1 5´-gcctgcaaccttgtctgag-3´ 5´-cagactccatcagggtaggg-3´ Eurofins MWG 
operon 
LCM 
VEGF 5´-ggagatccttcgaggagcactt-
3´ 
5´-
ggcgatttagcagcagatataagaa-
3´ 
Eurofins MWG 
operon 
LCM 
C-kit 5´-tgtaaggcctccaacgatgt-3´ 5´-cagagtgtgggcctggattt-3´ Eurofins MWG 
operon 
LCM 
CCSP 5´-gatcgccatcacaatcactg-3´ 5´-cagagttccgaagaagctga-3´ Eurofins MWG 
operon 
Lung homogenate 
GAPDH 5′-tgaggccggtgctgagtatgtcg-
3′ 
5′-ccacagtcttctgggtggcagtg-
3′ 
Eurofins MWG 
operon 
LCM 
Table 4: List of the primer sequences used for the real-time quantitative PCR. 
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2.2. Methods  
 
2.2.1. Lung isolation and tissue processing for paraffin embedding 
Mice were anesthetized with lethal dose of isofluran (liquid for inhalation; Baxter). A large 
incision was made up to the neck of the mouse. 10 ml cold PBS (Phosphate Buffered Saline; 
Dulbecco) was perfused through the right ventricle until lungs cleared of blood. After 
pulling back the skin above the head of the mouse to expose the throat, the rest of the rib 
cage was removed carefully and other tissues around to expose the trachea. The forceps 
was placed under the trachea to separate the trachea from the oesophagus. 2-3 ml 
paraformaldehyde (PFA cat#0335.3; Roth) at 4 % dissolved in 1x PBS (4.3 mM Na2HPO4, 
137 mM NaCl, 2.7 mM KCl, 1.4 mM KH2PO4) was injected into the trachea until the lungs 
inflate. Gently, lungs were dissected and dropped into 15 ml conical tube with a large 
volume of 4 % PFA and left at 4 °C overnight. After 24 h, lungs were washed and kept 
with PBS for a maximum of one week or in 50 % ethanol for a long-term period. For 
paraffin processing, the lungs were put into plastic cassettes and placed in tissue processor 
(ASP200 S: Leica Microsystems Nussloch GmbH, Germany) where they ran through 
increasing concentrations of alcohol which dehydrate the tissues, and in paraffin which 
infiltrate into the tissues; the next step, the tissues were embedded into paraffin blocks. 
 
2.2.2. Tissue preparation and histology 
 
2.2.2.1. Immunohistochemistry with DAB (3, 3’-diaminobenzidine) on paraffin-
embedded tissues 
10 µm paraffin-embedded sections were placed at 65 °C for 20 min (minutes) and serial 
steps of deparaffinization and hydration with decreasing concentration of alcohol were 
performed. The sections were incubated in 3 washes of rotihistol (cat#6640.4; Roth) for 10 
min each, then in 2 washes of 99.9 % of ethanol for 5 min each, 1 time in 96 % of ethanol 
for 5 min and 1 time in ethanol 70 % for 5 min. To block endogenous peroxidase, the 
tissues were immersed in 2 % BSA (bovine serum albumin, cat# K45-00; PAA 
Laboratories, Austria) with 0.5 % NP40 and 3 % NGS (normal goat serum). Slices were 
stained overnight with mouse monoclonal Oct4 primary antibody diluted (1:50) in 2 % 
BSA with 0.5 % NP40. The tissues were rinsed 3 times for 5 min each in 1x PBS, and 
incubated 1h at RT (room temperature) with appropriate biotin-labeled antibody (M.O.M 
kit cat#PK-2000; Vector Laboratories, Burlingame, Canada) at 1:1000. After 3 washing 
Section 2: Materials and  methods 
26 
steps in 1x PBS for 5 min, the tissues were incubated for 1h at RT with the ABC substrate 
(M.O.M kit); 2 drops reagent A + 2 drops reagent B in PBT (1x PBS with 0.1% Tween 20 
and rapidly vortexed). The slides were washed 3 times, incubated with 10 mg DAB tablet 
(cat#D4168; Sigma) in PBT solution with 30 % H202 for 15-30 min at RT. The 
counterstaining with DAPI (1:1000) was for up to 10 min and the slices were mounted with 
mowiol (4-88 reagent cat#475904; Merck chemical Ltd). 
 
2.2.2.2. Immunofluorescence on paraffin-embedded tissues  
Deparaffinization and hydration steps were performed as described previously and the 
tissues were permeabilized with methanol 100 %. The sections where submerged in 
distillated water for 5 min and incubated for 10 min at 37 °C with trypsin working solution 
(Digest All cat#003008; Invitrogen) for antigen unmasking. After washing with 1x PBS, 
the tissues were blocked with 5 % BSA for 1h at RT and incubated with appropriate 
primary antibodies (1:50-500) diluted in histobuffer (3 % BSA , 0,2 % TritonX-100 in 
PBS) for 1h at RT or overnight at 4 °C. They were after that washed with 1x PBS and 
incubated with appropriate secondary antibodies (1:500-1000) for 1h at RT, washed with 
1x PBS and counterstained with DAPI (1:1000) for 10 min. The slices were mounted with 
mowiol and scanned with Zeiss LSM 710 laser scanning confocal microscope. 
 
2.2.2.3.  Resorcin-fuchsin staining on paraffin-embedded tissues 
After deparaffinization and hydration steps, the slices were immediately put in resorcin-
fuchsin (cat#2E-030; Waldeck) working solution (173 g of 70 % ethanol, 7.2 ml of 25% 
HCl, and 10 ml weigert resorcin-fuchsin) and kept overnight. After one step of washing 
with distillated water, the slices were counterstained with Kernechtrot-Aluminium sulfate 
(cat#2E-012; Waldeck) and washed 2 times again with water, dehydrated with ethanol (1 
time in 70 % for 1 min, 1 time in 96 % for 2 min and 2 times in 99.9 % for  2 min) ,washed 
3 times with rotihistol ( 2 times for 10 min and 1 time for 5 min), then dehydrated in 2 
washes of isopropanol for 5 min and transferred in xylene for 5 min. The slices were 
afterward mounted with pertex (cat# 1.07960.0500; Merck). 
 
2.2.3. Immunocytochemistry of sorted cells: preparation of cytospin from single 
sorted cell suspension 
Directly after sorting (2.2.4), the cells were washed in PBS and resuspended in 10 % FCS. 
The slides were mounted with filter pad paper in a metal holder; 100 µl of PBS per 5 x 104 
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cells were loaded onto the slides and spin down at 400 x g for 5 min. The cells were fixed 
with methanol 100 % for 10 min, washed with water, blocked with 5 % BSA for 1h and 
incubated with the appropriate primary and secondary antibodies for 20 min each and 
counterstained with DAPI up to 10 min. The slices were after that mounted with mowiol 
and scanned. 
 
2.2.4. Flow cytometry and fluorescence-activated cell sorting (FACS) 
Twelve- to twenty-weeks-old mice lungs were isolated and filled with 1-2 ml dispase (cat# 
354235; BD Bioscience) by intra-tracheal instillation; dissected and minced with sterile 
scalpel and incubated with 2 µg/ml collagenase B (cat# 11088815001; life sciences) and 
0,001% (w/v) DNAse (cat#18535; Serva Electrophoresis) in DMEM for 15 min at 37 °C. 
The resulting cell suspension was filtered through 100 µm (cat#352360) and 40 µm cell 
strainers (cat#352340; BD Falcon) and centrifuged at 400 x g, 5 min at 4 °C. Cells were 
resuspended in cell blood lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) 
for 5 min, washed in PBS and resuspended in FACS-buffer (PBS, 2 mM EDTA, 25 mM 
HEPES) at 1 million cells/100 µl and incubated for 20 min on ice with a mixture of 
appropriate antibodies (1µl/5million cells) . Labeled cells were washed with PBS and 
resuspended in FACS-buffer for flow cytometry or FACS sorting. Cells were labelled with 
DAPI for cell viability. The flow cytometric analyses were performed with BD LSR II flow 
cytometer and the data were interpreted with flowJo7.6.4 software. The BD FACSAria III 
cell sorter was used for cell-sorting procedures. 
 
2.2.5. Cell suspension cultures and clonogenic assays 
Cells were sorted and directly collected in FACS-tubes filled with α-MEM medium (cat# 
41061; Invitrogen) containing 10 % (v/v) FCS, 1× penicillin/streptomycin (100× stock 
solution), 1× insulin/transferrin/selenium (100× stock solution cat#51500-56; Invitrogen), 
2 mM l-glutamine (cat#P04-80100; PAN Biotech) and 0.0002 % (w/v) heparin 
(cat#H3149; Sigma), and immediately centrifuged for 5 min at 400 x g at 4° C, washed , 
and resuspended in the α-MEM cocktail medium. Oct4 positive cells sorted based on GFP 
fluorescence were cultured in suspension in normoxic conditions (21 % O2, 5 % CO2, 37° 
C) for 5 days and the medium was exchanged every two days. Epithelial stem/progenitor 
cells (ESPCs) selected based on CD45negCD31negEpCAMhighCD24low, were in contrast, 
when sorted for clonogenic assays, tested for differentiation on 3D matrigel cultures mixed 
with feeder cells. 
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 The sorted cells were resuspended in the medium and mixed with the matrigel (1:1). 
Millicel inserts (Millicel® 0.4 µm, 12mm diameter, cat#PICM01250; Millipore) were 
placed in 12 well-plates and 90 µl of the cell suspension was put on the top of the insert. 
After, this plate was incubated in normoxic condition for 5 min and 400 µl of the cocktail 
medium was added into the plate. The cultures were grown in hypoxic conditions (1 % O2, 
5 % CO2, 37 °C) for one week and the medium was exchanged every two days. The cultures 
were imaged with light microscope and then stained with appropriate antibodies for the 
immunofluorescence confocal microscopy analyses.  
 
2.2.6. Western blot analysis 
Proteins were isolated from lung tissue lysates. 20 -30 mg of tissues were transferred into 
bead tubes and homogenized using a precellys homogenizer (Precellys® 24/ PeqLab; 91-
PCS24) at 6500 rpm for 1 min in RIPA lysis buffer (cat# 89901; Thermo Scientific) with 
protease and phosphatase inhibitor cocktail (cat#18161284; Thermo Scientific). After 
homogenization, the samples were centrifuged at 12 000 rpm at 4 °C for 30 min. The 
supernatant was collected in new tubes and a colorimetric protein assay kit (Bio-Rad 
protein assay kit: cat#210003399) was used to measure the concentration of the proteins. 
For the standard curve, a serial dilution of 0.1, 0.2, 0.4, 0.8 and 1.6 ng/µl of BSA was 
prepared. 5 µl of each dilution step and 5 µl of the protein samples were put in a 92 well-
plate. 5 µl of distilled water were used for the blank sample. A mixture of 25 µl of S and 
A reagents (1:20), and 200 ml of B reagent from the protein kit were added into each well 
containing a sample. The plate was left 10 min at RT and the concentration of the proteins 
was determined with the monochromator Infinite® 200 NanoQuant microplate reader 
(Tecan Group Ltd.  Männedorf, Switzerland). Before electrophoresis, the samples were 
mixed with Laemmli buffer [375mM, SDS 10 % (w/v), glycerol 50 % (v/v), β-
mercaptoethanol 12.5 % (v/v),  bromophenol blue 0.02 % (v/v)], centrifuged for 12 seconds 
at 12 000 rpm, heated at 95 °C for 5 min  and then centrifuged for 12 seconds before 
loading. The samples were run on 10 % SDS-PAGE (375 mM Tris/Cl pH 8.9, 10 % 
acrylamide, 0.20 % SDS, 0.05 % APS and 0.10 % TEMED) for 1h 15 min with 80-100 V 
and transferred onto a nitrocellulose membrane (cat# S80209: Pall Corporation, Dreieich, 
Germany) for 1h 15 min with 100 V. The membrane was after that rinsed with TBS/T (tris 
buffered saline with 1 % Tween 20), blocked in 5 % milk (cat# M740: Sigma-Aldrich, St-
Louis, USA) with TBS/T for 1h 30 min at RT on an orbital shaker plate. The membrane 
was then incubated with  the appropriate primary antibodies 1:1000 ( sc-5279) overnight 
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at 4° C on an orbital shaker plate, then washed 3 times for 5 min each in a large volume of 
TBS/T and incubated 1h with the secondary antibody 1:3000; then washed 3 times for 10 
min each with TBS/T. The Super Signal® reagent (1:1) (Thermo Scientific: prod# 34096) 
was used for developing the membrane. The bands were detected with the luminescent 
image analyzer LAS-4000 mini (Fujifilm, Tokyo, Japan). After the exposure, the membrane 
was washed 4 times for 5 min each in TBS/T, submerged in 25 ml stripping buffer 
(cat#21059; Thermo Scientific) and incubated for 1h at RT with agitation on a shaker plate. 
After two steps of washing for 10 min each, the membrane was blocked in 5 % milk and 
the immunodetection protocol was repeated as described previously with mouse 
monoclonal anti-β-actin antibody 1:5000 (cat#A5316; Sigma) and the appropriate 
secondary antibody. 
 
2.2.7. Reverse-transcription PCR 
The reverse-transcription PCR (RT-PCR) was carried with high capacity cDNA reverse 
transcription kit (Applied Biosystems; USA). The master mix per 20 µl reaction contained 
2 µl of 10x RT buffer, 0.8 of 25x dNTP mix (100 mM), 2 µl of 10x random primers, 4.2 
µl nuclease-free water and 100 ng of total RNA per 10 µl reaction (table 5). The volume 
of the master mix was calculated according to the required number of reactions and all the 
steps were carried out on ice. The RT-PCR (2.2.8) was run with the thermal cycling 
program referred in table 6. 
 
Components  Volume  per  reaction (µl) 
25X dNTP Mix (100 mM) 2 
10X RT Random Primers 0.8 
Reverse Transcriptase 2 
Nuclease-Free H2O 4.2 
RNA template ( up to 1 µg) 10 
Total per reaction  20 
Table 5: Preparation of the master mix for the cDNA synthesis. 
Parameters Step 1 Step 2 Step 3 Step 4 
Temperature ( °C)  25 37 85 4 
Time  (minutes) 10 120  5 ͚ 
Table 6: Thermal cycling program of the RT-PCR.  
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2.2.8. Real- time quantitative PCR 
To ensure the efficiency of the PCR, primer efficiency test was carried out. The efficiency 
of the PCR was tested by performing ten-fold dilution series of the cDNA templates in 
triplicate (1:10; 1:100; 1:1000). By using the Ct slope method (see the calculation below), 
the baseline and threshold were set and the slope of the standard curve was translated into 
an efficiency value: 
 
 
 
The PCR was efficient between 90–100 % (−3.6 ≥ slope ≥ −3.3). The efficiency was 100 
%, when the Ct values of the 10 fold dilution were 3.3 cycles apart. The real time PCR 
reaction mixture and the thermal cycling program are summarized in tables 7 and 8. The 
real time PCR was run with ViiA™ 7 Real-Time PCR System (Applied Biosystems) using 
SYBR Green dye for the detection of the double-stranded DNA; the mRNA levels were 
expressed as ΔCt values compared to GAPDH housekeeping gene control. 
 
Components  Voulume per reaction (µL)  
SYBR Select Master Mix 10 
Nuclease-Free H2O 7 
Foward primer 0.5 
Reverse primer 0.5 
cNDA template 2 
Total per reaction 20 
Table 7: Master mix for the real-time quantitative PCR reaction. 
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Parameters 
Hold stage PCR stage Melt curve stage 
Step 1 Step 2 Step1  Step 2 Step 3 Step 1 Step 2  Step 3 
Temperature  (°C) 50 95 95 59 72 95 60 95 
Time (minutes) 2 10 15 15 20 5 1 15 
Table 8: Thermal cycling program for the real-time quantitativePCR. 
 
2.2.9. Laser capture microdissection  
This method required frozen tissues which were labeled prior the microdissection. 10 µm 
tissues sections were placed in 70 % ethanol for 60 seconds and directly passaged in sterile 
distillated water for 10 seconds. The slides were then after stained with hematoxylin 
(cat#MHS16; Sigma) for 10 seconds, washed in sterile water and tap water for 10 seconds 
each. Rapid steps of dehydration with increasing concentrations of ethanol (15 seconds 
each; in 70 %, twice in 95 %, once in 100 % and 1 min in 100 % ethanol) were performed 
in order to maintain the integrity of the RNA. The microdissected samples were collected 
in tubed filled with 350 µl of RLT buffer (QIAGEN), vortexed for 30 seconds and RNA 
was isolated using the RNeasy Plus Micro Kit (QIAGEN® Kit cat#74034). The RT-PCR 
(see master mix reaction in table 9 and the thermal cycling in table 10) was performed with 
cDNA kit from Bio-Rad (iScript™ Select cDNA Synthesis Kit #170-8896) and the mRNA 
levels of different genes were measured by real-time quantitative PCR during 40 cycles of 
amplification (see master mix reaction in table 7 and the thermal cycling in the table 8). 
The primers used for this test identified Oct4, PDGFR-b, Sca-1, VEGF, vimentin, C-kit 
gene expression levels. Primer sequences are shown in table 4. The mRNA expression 
levels were shown as ΔCt values compared to GAPDH housekeeping gene control.  
   Components  Volume  per  reaction (µl) 
5X iScript reaction mix 4 
iScript reverse transcription 1 
Nuclease-Free H2O 5 
RNA template ( 100 fg to 1µg) 10 
Total per reaction 20 
Table 9: Master mix for the cDNA synthesis after LCM. 
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Parameters  Step1  Step 2 Step 3 Step 4 
Temperature (°C) 25 37 85 4 
Time (minutes) 5 30 5 ͚ 
Table 10: Thermal cycling program for the RT-PCR after LCM samples. 
 
2.2.10. Naphthalene injury model 
Naphthalene was injected intraperitoneally at 250 mg/kg in 30 mg of powder (Sigma; 
cat#84679) per ml of corn oil (Sigma; cat#8001-30-7) in conscious adult mice (> 8 weeks 
old). The control group received the equivalent volume of corn oil per body weight. The 
treatment was given once and the lungs were harvested at different time points to perform 
the analyses. 
 
2.2.11. Pneumonectomy (PNX) model 
 
2.2.11.1. Preparation of the animal 
Mice were first put in a chamber filled with 5 % isofluran until they reached deep 
anesthesia. Depth of anesthesia was monitored via lack of response to the hind toe pinch 
and subjective respiratory rate. The eyes were protected from drying by application of 
Dexpanthenol-ointment. The animal was directly placed on a warm platform under a 
microscope and intubated orally with a 21G cannula. Afterwards, the intubation tube was 
carefully introduced into the trachea and connected to a volume-controlled ventilator 
(100/min respiratory rate, puff volume 250 µl). The surgery was performed aseptically; the 
animal was maintained under isofluran dispenser at 2-2.5 % which was itself connected to 
a ventilator. 
 
2.2.11.2. Surgery procedure 
Under deep anesthesia, 8-10 mm cut was made between the 4th and 5th left rib. The chest 
cavity was opened and the left lung was lifted cautiously out of it. The left lung was after 
that, ligated and resected at the left hilus (site of incoming and outgoing vessels/bronchi). 
The thorax was then closed with one suture around the 4th and 5th rib. Skin was continuously 
sutured. Sterile glucose solution (1 ml 5%) was injected subcutaneously to serve as fluid 
support in order to maintain the animal's hydration. After PNX, the animal was placed 
under a heat lamp and monitored for 60 min. Post-surgery analgesia was applied through a 
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reinjection of buprenorphine (0.05 mg/kg) after 8 h. Carprofen (4 mg/kg) was administered 
ad libitum via drinking water for 5 days. The sham procedure was similar to the PNX but 
without left lung resection. The chest was left open for 5 min to mimic the procedure of 
PNX and then the rib cage was closed as previously described. 
 
2.2.12. In vivo lung organoid assays and kidney capsule model 
 
2.2.12.1. Preparation of lung organoid for the transplantation  
Single cell suspension of embryonic lung cells dissociated from E14.5 mouse was prepared 
and centrifuged at 400 x g for 5 min. The compact pellet was mixed up and down; 5-6 µl 
were pipetted on the top of a 13 mm sterile polycarbonate filter with 8 microns pore size 
(Millipore; cat#TETP01300) floating on the top of DMEM + 10 % FCS. Afterwards, the 
organoids cultures were incubated at 37 °C for 24 h (Fig. 5). 
 
2.2.12.2. Organoid transplantation: kidney capsule model 
The organoids were implanted under the kidney capsule of immunodeficient NOD/SCID 
mice 24 h after the organoid´s preparation. The animal was first anesthetized as described 
for the PNX surgery. When the mouse was fully anesthetized, the animal was placed on 
warm towels on ventral position. The skin was cleaned with betadine; an incision of 2-3 
cm was made with scissors from the base of the tail. The skin was separated from the 
dermis; the kidney was then visible. With the thumbs on the animal’s abdomen, a gentle 
pressure was applied to expose the kidney out of the body. With the forceps, the organoid 
was inserted under the capsule and the kidney was immediately replaced into the body. The 
skin was then closed and sutured. After surgery the mouse was placed in a clean cage to 
recover. Ibuprofen 0.11 mg/ml (30 mg/kg/day) was administered ad libitum via drinking 
water for 5 days post-surgery. 
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Fig. 5 Different steps of the kidney capsule model. 
Step 1: isolation of E.14.5 mouse lung at day 1. Step 2: lung tissue digestion at day 1. Step 3: 
preparation of the pellet suspension which forms organoids after 24h in culture at 37 °C. Step 4: 
after 24h in culture, transplantation of the organoids under the kidney capsule of an 
immunodeficient mouse. 
   
2.2.13. Statistical analyses  
Data were assembled using GraphPad Prism software (GraphPad Software, USA) and One-
way ANOVA (for comparing three or more groups) or Two-way ANOVA (for comparing 
different parameters in one or several groups). Data were expressed in mean ± SEM 
(standard error of the mean) and considered significant when the p value was less than 0.05 
(*p < 0.05). 
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SECTION 3: RESULTS 
3.1. Identification of BASCs in adult mouse lung tissues and in lung organoid 
transplants 
BASC cells were identified based on the co-expression of CCSP, the bronchiolar 
epithelial Clara cell marker and SPC, the alveolar epithelial type 2 cell marker. BASCs 
were present at the bronchioalveolar duct junction (BADJ) between the terminal 
bronchiole and alveolar space (Fig. 6A). The higher magnification of the BADJ showed 
overlapping of CCSP and SPC markers in BASCs (Fig. 6B; merge). In addition, we 
obtained 3-dimensional images of BASCs using different focal planes within the tissue 
sections called z-stacks (Fig. 7A-D) which showed as well overlapping between CCSP 
and SPC markers in the cytoplasmic compartment. BACS were identified using and we 
in vivo lung organoid transplantation (2.2.12). Embryonic day 14.5 lung cells were 
cultured for 24 h in normoxic conditions and then transplanted under the kidney capsule 
of NOD/SCID immunodeficient mice. The organoids were grown for 6 (Fig. 8A) and 14 
days (Fig. 8B), and the histological analyses of the organoid sections showed a structure 
which resembled to airway architecture (Fig. 8C; 8D). The immunofluorescence staining 
was carried out on day 14 organoid sections and showed the presence of cells which co-
expressed CCSP and SPC (Fig. 9A; 9B). 
 
 
Fig. 6 Identification of BASC cells in lung tissues of adult wild type mouse. 
Immunofluorescence for CCSP (red), SPC (green) and nuclear stain DAPI (blue) on mouse lung 
tissue. (A) Co-lacalization of CCSP and SPC at the bronchiolaveolar duct junction (BADJ) between 
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the terminal bronchiole and the alveolar space. (B) Higher magnification, CCSP and SPC in the 
cytoplasmic compartment. 
 
 
Fig. 7 3D co-localization analysis of a BASC cell.  
(A), (B), (C) and (D) demonstrate a BASC cell (green arrows) in 3D images acquired 
using different focal planes (z-stacks) within 10 µm paraffin-embedded tissue sections 
of adult mouse lung. Including all focal planes, a co-localization between CCSP and 
SPC markers in the cytoplasmic compartment is shown. 
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Fig. 8 Formation of organoids under the kidney capsule and staining of the organoid sections. 
E.14.5 organoids under the kidney capsule of immunodeficient NOD/SCID mice. (A) Day 6 organoid 
under kidney capsule. (B) Day 14 organoid. (C, D) Resorcin-fuchsin staining of the organoid sections. 
(C) After 6 days, and (D) 14 days, organoids develop into an airway-like structure.  
 
 
Fig. 9 Identification of BASCs in organoid sections. 
(A) Paraffin embedded-sections of day 14 organoids and immunofluorescence staining for CCSP (red), 
SPC (green) and DAPI (blue). CCSP staining is localized in structures resembling to bronchi, SPC staining 
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is localized in alveolar sac-like structures. (B) CCSP/SPC dual positive cells were localized near a junction 
between bronchi and alveolar sacs (white arrows). (B) Higher magnification, co-localization of CCSP and 
SPC in the cytoplasmic compartment. 
 
3.2. Effect of naphthalene-induced injury in adult mouse lung 
Mice were treated with naphthalene, which induced bronchiolar Clara cells damage. The 
organs were collected at different time points. They were harvested at day 3, 6, 10 and 14 
post-injury. The tissues were analyzed by light microscopy using resorcin-fuchsin 
staining. The tissues treated with corn oil did not present any damage of the epithelium 
(Fig. 10A). In contrast, tissues treated with naphthalene showed the depletion of Clara 
cells at day 3 post-injury (Fig. 10B). At day 6 post-injury, the bronchiolar epithelium was 
repopulated (Fig. 10C); the cells looked flattened compared to the corn oil where the cells 
showed a cuboidal shape (Fig. 10A). The same observation was made at day 10 and day 
14 post-injury (Fig. 10D; 10E); the bronchiolar epithelium was regenerated and the cells 
displayed a flat shape. No alveolar damage was observed on the tissues treated with 
naphthalene in comparison to the corn oil control tissues. To support the histological 
analyses, real-time PCR reaction was run with day 3, 7, 14 and 21 post-injury samples 
(these samples were kindly provided by Prof. Dr. Saverio Bellusci from the Excellence 
Cluster Cardio-Pulmonary-System, Justus-Liebig-University, Giessen) and the data 
obtained confirmed that the levels of CCSP expression were significantly decreased at 
days 3 post-injury and re-increased gradually from day 7 till day 21 post-injury; and 80 
% of Clara cells recovery was thus obtained at day 21 post-injury (Fig. 11). 
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Fig. 10 Resorcin-fuchsin staining of mouse lung tissues after naphthalene injury. 
Lung from adult wild type mice after corn oil treatment and naphthalene treatment. (A) Corn oil 
after 3 days shows a normal epithelium (arrows). (B) Naphthalene treatment after day 3 shows 
epithelial damages (arrows). (C) Day 6 post-injury shows a repopulated epithelium (arrows). Note 
that the cells have a flat shape compared to the corn oil. (D) Day 10 post-injury, the epithelium is 
repopulated (arrows). (E) Day 14 post-injury, the epithelium is repopulated (arrows). 
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Fig. 11 mRNA levels of CCSP at different time points after naphthalene injury. 
Level of CCSP expression after corn oil treatment and naphthalene treatment in 
adult wild type mouse lung. CCSP expression decreased significantly after 3 days 
post-injury and increase till 21 days post- injury. Note that at day 21, 80 % of CCSP 
expression was recovered. Data are expressed in mean ± SEM and n ≥ 3. **p < 0.01; 
*** p < 0.001. 
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3.3. BASCs and Clara cells are damage resistant and proliferate upon 
naphthalene injury 
Immunofluorescence analyses were carried out on tissues embedded with paraffin after 
naphthalene injury and demonstrated that BASCs and Clara cells were damage-resistant 
(Fig. 12). As we did not see a clear difference between day 10 and day 14 post-injury in 
histological analyses with resorcin-fuchsin staining described in the previous paragraph, 
the data were collected only at day 3, 6, and 10 post-injury. Staining based on BASCs 
markers and PCNA, a marker for the detection of proliferating cells was performed. As 
seen in the Fig. 12A, at day 3 post-injury, the tissues treated with corn oil were intact. 
The tissues treated with naphthalene showed a depletion of Clara cells everywhere except 
at the BADJ where BASCs reside, and also at the neuroendocrine cell-associated Clara 
cells area; the damage resistant Clara and BASCs proliferated as they expressed PCNA 
in the nuclear compartment (Fig. 12B). At day 6 post-injury, Clara cells continued to 
express PCNA but BASCs did not express the marker anymore (Fig. 12C, 12D). A close 
look in the alveolar region at day 6 post-injury revealed the presence of clusters of Clara 
cells and BASCs. As observed in the bronchiolar epithelium, Clara cells expressed PCNA 
and BASCs did not (Fig.12E; 12F). At day 10 post- injury, the staining demonstrated one 
more time that BACS stopped to express PCNA and Clara cells were still expressing 
PCNA (Fig.13). Others analyses including flow cytometry and real-time PCR were 
performed. Flow cytometric analyses showed that the number of Clara cells (Fig. 14A) 
and BASCs (Fig. 14B) in lung homogenates were significantly increased at day 6 post-
injury and then decreased at day 10 and 14 post injury. 
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Fig. 12 Immunofluorescence of mouse lung tissues after naphthalene injury. 
Immunofluorescence of adult lungs harvested after 3 and 6 days post-injury, processed with paraffin and 
stained with CCSP (red), SPC (yellow), PCNA (green), and DAPI (blue). (A) Corn oil at day 3 post-injury, 
no damage seen on tissue. (B) Day 3 post-injury, depletion of Clara cells. Clara cells (red arrow) and BASCs 
(yellow) are resistant to injury and express PCNA (green). (C) Day 6 post injury, the bronchiolar epithelium 
is regenerated. PCNA is expressed in Clara cells. (D) Day 6 post injury, PCNA is not expressed in BASCs 
(yellow arrow). (E) Day 6 post injury, Clara cell organized in cluster (red arrow) in the alveoli do no express 
PCNA. (F) Day 6 post- injury, Clara cells and BASCs organized in clusters in the alveoli. PCNA is 
expressed in Clara cells (red arrow) but not in BASCs (yellow arrow). 
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Fig. 13 Immunofluorescence of adult mouse lung tissues 10 days post-injury.  
Immunofluorescence of adult lungs harvested after 10 days post-injury, processed with 
paraffin and stained with CCSP (red), SPC (yellow), PCNA (green), and DAPI (blue). The 
bronchiolar epithelium is regenerated; PCNA is expressed in Clara cells (red arrows) but not 
in BASCs (yellow arrow).  
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Fig. 14 Flow cytometric analyses and quantification of Clara cells and BASCs after naphthalene.  
Adult mouse lungs were isolated 3, 6, 10 and 14 days after treatment with corn oil (Co) or naphthalene 
(naph). Cell suspensions were incubated with CCSP, SPC and appropriates secondary antibodies. (A) 
Relative number of Clara cells. (B) Relative number of BASCs. Data are expressed in mean ± SEM and 
n ≥ 3. *p < 0.05; **** p < 0.0001. ccsp-Co: cells from corn oil-treated mice and stained with CCSP; 
ccsp-naph: cells from naphthalene-treated mice and stained with CCSP; basc-Co: cells from corn oil-
treated mice and co-stained with CCSP and SPC; basc-naph: cells from naphthalene-treated mice and 
co stained with CCSP and SPC. 
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3.4. BASCS and Clara cells proliferate after pneumonectomy 
Pneumonectomy (PNX) was carried out on adult mice. The left lung was resected. The 
organs were harvested at day 3 and day 7 post-operation and histological analyses were 
performed on paraffin-embedded sections. The tissues were stained with BASCs markers 
and PCNA. The results showed that at day 3 post-operation, there was no proliferation 
observed neither in Clara cells, alveolar type 2 cells nor in BASCs since they were not 
expressing PCNA (Fig. 15A). On the contrary, at day 7 post-operation, all cell types did 
express PCNA in the nuclear compartment (Fig.15B). 
 
 
Fig. 15 Immunofluorescence of adult mouse lung tissues after pneumonectomy. 
After pneumonectomy (PNX), lungs were isolated at day 3 and 7 post- surgery. The lung were embedded 
in paraffin and co-stained with CCSP (red), SPC (yellow), PCNA (green) and DAPI (blue). (A) Day 3 
post- surgery neither Clara cells (red arrow), alveolar type 2 cells (green arrows) nor BASCs (yellow 
arrow) were positive for PCNA. (B) Day 7 post injury, Clara cells, alveolar type 2 cells and BASCs were 
positive for PCNA. 
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3.5. Evidence of BASCs  as stem/progenitor cells of adult mouse lung 
 
3.5.1. Relation of BASCs to EpCAMhighCD24low epithelial stem/progenitor cells in 
adult wild type mice 
FACS analyses, cytospin and clonogenic assays of epithelial stem/progenitors cells 
(ESPCs) (1.8) were carried out to determine the relation of BASCs to ESPCs. The cells 
isolated from adult mouse lungs were stained for CD45 and CD31 to exclude the 
hematopoietic cells and the endothelial cells. EpCAM (epithelial cell adhesion marker), 
a marker of epithelial cells and CD24 mostly found at the surface of B lymphocytes and 
granulocytes, were used to discriminate ESPCs from others mouse lung cell types. The 
EpCAMhighCD24low cell fraction was isolated via FACS. Cells were cytospun or cultured 
in 3D matrigel cultures. Using FACS analysis, the EpCAMhighCD24low cell fraction was 
gated (Fig. 16) .DAPI was used to exclude dead cells (Fig. 16A). CD45 and CD31 FITC-
labeled cells were as well excluded (Fig. 16B) and EpCAM Cy7-labeled positive cell 
positive fraction was set for EpCAMhighCD24low. CD24 cells were labeled with PercP 
(Fig. 16C). Immunofluorescence after cytospin showed that the EpCAMhighCD24low cell 
fraction contained BASCs based on their co-expression for CCSP and SPC (Fig. 16D: 
merge image). The sorted cells were also used for clonogenic assay on matrigel cultures. 
After 7 days in hypoxic culture conditions, the matrigel cultures were stained. The assays 
showed different type of colonies (Fig. 17). Some colonies were expressing neither CCSP 
nor SPC (Fig. 17A); some were expressing only SPC (Fig.17B) or CCSP (Fig.17C) and 
others were co-expressing both CCSP and SPC identified as BASCs colonies (Fig. 17D). 
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Fig. 16 FACS analyses and immunofluorescence of sorted ESPCs from adult wild type mice.  
For flow cyometric analyses, whole lungs cell of adult mouse lung were isolated. The cell suspension was 
incubated with APC labeled CD45 and CD31, PE-Cy7 labeled EpCAM and PercP labeled CD24. (A) Dot 
plot representation of dead cells exclusion (DAPI positive cells). (B) Dot plot representation of CD45 and 
C31 positive cells exclusion (EpCAM negative cells); EpCAM positive cells represent a percentage of 40.9 
% of the total epithelial cell population (EpCAM positive cells). (C) Dot plot representation of 
EpCAMhighCD24low epithelial stem/progenitor cell population (ESPCs) which represent 3.57% of the total 
epithelial cell fraction (EpCAM positive cells). (D) The EpCAMhighCD24low EPSC cell population was 
sorted and cytospun. The immunofluorescence of EpCAMhighCD24low EPSC cell population reveals the 
presence of dual CCSP/SPC positive cells which represent BASCs (red arrows and merge). 
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Fig. 17 Clonogenic assays of sorted ESPCs based on EpCAMhighCD24low in the presence of matrigel. 
After EpCAMhighCD24low EPSC cell population was sorted and cultured in presence of matrigel under 
hypoxic conditions (1% O2), ESPCs generate different size of colonies after 7 days in culture (see A, B, C 
and D bright field image). (A) The immunofluorescence analyses reveal that the bigger colonies are 
negative for SPC and CCSP. (B) The intermediate sized colonies include SPC expressing alveolar type 2 
cells or (C) CCSP expressing Clara cells). (D) The smaller colonies include double positive CCSP/SPC 
expressing BASCs.  
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3.5.2. Relation of BASCs to EpCAMhighCD24low ESPCs in transgenic mice 
Single and double transgenic knock in mice expressing YFP and mCherry fluorescent 
proteins under the control of SPC and CCSP promoters respectively were used. Lines 
were created and kindly provided by Dr. Marten Szibor, MPI Bad Nauheim. CCSP-
mCherry mouse line was used to detect Clara cells based on mCherry endogenous 
fluorescence. SPC-YFP mouse line was used for the detection of alveolar type 2 cells 
based on YFP endogenous fluorescence, and the double transgenic CCSP-mCherry/SPC-
YFP for BASCs detection. ESPCs fraction was gated based on EpCAMhighCD24low (Fig. 
18) expression. Dead cells were excluded with DAPI (Fig. 18A); hematopoietic and 
endothelial cells were excluded with CD45-CD31 labeled with APC. EpCAM positive 
cell fraction represented 20.6 % (Fig. 18B) of the whole lung cell population. 
EpCAMhighCD24low labeled with Cy7 and PercP represented 1.23 % of the total EpCAM 
positive cell fraction (Fig. 18C). Within the EpCAM positive cell fraction (Fig. 18B), 
CCSP-mCherry expressing Clara cells represented 3. 03 % of the total EpCAM positive 
cell population (Fig. 19B) and 29.7 % of the 3.03 % were EpCAMhighCD24low positive 
ESPCs (Fig. 19C). The same analysis was achieved for SPC-YFP expressing alveolar 
type 2 cells which represented 21.3 % of the total EpCAM positive cell population (Fig. 
20A); the relation of SPC-YFP to EpCAMhighCD24low showed that only 1.32 % of the 
21.3 %  SPC cells were EpCAMhighCD24low positive ESPCs (Fig. 20B). CCSP-
mCherry/SPC-YFP double positive BASCs represented a small fraction of 0.142 % cells 
of the total EpCAM positive cell population (Fig. 21B). The analysis of 
EpCAMhighCD24low (Fig. 22A) using these double transgenic mice revealed that this 
population was highly enriched in CCSP expressing Clara cells (66.7 %), but SPC 
expressing alveolar type 2 cells (14 %) and BASC cells (8.77 %) were less abundant (Fig. 
22B). 
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Fig. 18 Identification of EpCAMhighCD24low cell population in CCSP-mCherry/SPC-YFP transgenic 
knock in mice. 
Cells from double transgenic mice expressing mCherry and YFP fluorescent proteins under the control of 
CCSP and SPC promoter were isolated and analyzed by flow cytometry. (A) Exclusion of dead cells 
positive for DAPI. (B) Exclusion of CD45 and CD31 positive cells labeled with APC. EpCAM positive 
cells labeled with PE-Cy7 represent a percentage of 20.9 %. (C) Dot plot representation of 
EpCAMhighCD24low EPSC cell population which represent 1.23 % of the total epithelial cell fraction 
(EpCAM positive cells). 
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Fig. 19 A cell fraction of CCSP-mCherry positive cells is EpCAMhighCD24low. 
Cells from transgenic mice expressing mCherry fluorescent protein under the control of the CCSP 
promoter were isolated and analyzed by flow cytometry. (A) Negative control with unstained cells. (B) 
CCSP-mCherry expressing Clara cells represent 3.03 % of EpCAM positive cells (not shown but the 
same gating as in Fig.18B was used). (C) In the fraction of 3.03 %, 29.7 % of CCSP-mCherry positive 
cells are EpCAMhighCD24low epithelial stem/progenitors cells (ESPCs).  
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Fig. 20 A cell fraction of SPC-YFP positive cells is EpCAMhighCD24low. 
Cells from transgenic mice expressing YFP fluorescent protein under the control of the SPC promoter 
were isolated and analyzed by flow cytometry. (A) SPC-YFP expressing alveolar type 2 cells represent 
21.3 % of EpCAM positive cells (not shown but the same gating as in Fig.18B was used). (B) In the 
fraction of 21.3 %, 1.32 % of SPC-YFP positive cells are EpCAMhighCD24low epithelial stem/progenitors 
cells (ESPCs).  
 
Fig. 21 Identification of BASCs in CCSP-mChrerry/ SPC-YFP double transgenic knock in mice. 
Cells from double transgenic mice expressing mCherry and YFP fluorescent proteins under the control 
of CCSP and SPC promoter were isolated and analyzed by flow cytometry. (A) Negative control with 
unstained cells. (B) CCSP-mCherry/SPC-YFP expressing BASCs represent 0.142 % of EpCAM positive 
cells (not shown but the same gating as in Fig.17B was used) 
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Fig. 22 BASCs are included in EpCAMhighCD24low cell population. 
Cells from double transgenic mice expressing mCherry and YFP fluorescent proteins under the control 
of CCSP and SPC promoter were isolated and EpCAMhighCD24low ESPC cell population was analyzed. 
(A) Representative dot plot of EpCAMhighCD24low ESPC cell population gating. (B) The analysis of the 
EpCAMhighCD24low ESPC cell population in the four-quadrant contour plot displays 14 % of SPC-YFP 
expressing alveolar type 2 cells (Q1), 66.7% of CCSP-mCherry expressing clara cells cells (Q3) and  8.77 
% of double  SPC-YFP/CCSP- mCherry positive cells which are BASCs (Q2). 
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3.6. BASCs do not express Oct4  
Paraffin-embedded tissues sections from Oct4GFP transgenic mouse lungs were stained. 
CCSP, SPC were used to identify BASCs. GFP was used to identify Oct4 in order to 
determine the stemness of BASCs. The data showed the presence of BASCs at the BADJ 
co-expressing CCSP and SPC, but Oct4 was not expressed in these cells (Fig. 23). 
 
 
Fig. 23  Immunofluorescence analysis of Oct4 expression in BASCs. 
Oct4GFP adult mouse lung were isolated; the tissues were embedded in paraffin 
and stained with CCSP (red), SPC (yellow), GFP (green) and DAPI (blue. (A) 
BASCs were identified at the BADJ (red square). (B Higher magnification of 
BASCs, Oct4 is not expressed in BASCs. 
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3.7. Identification of Oct4 in adult mouse lung tissues 
 
3.7.1. Oct4 is expressed in adult mouse lung tissues 
Western blot analyses were performed to detect the expression of Oct4 in whole lung cell 
lysate. Samples from adult wild type and Oct4GFP transgenic mice were used. A band of 
50 kDA was detected using Oct4 antibody in wild type cell lysate (Fig. 24A) and a band 
of 27 kDa was detected with the GFP antibody in transgenic cell lysate (Fig. 24B). 
 
 
Fig. 24 Western blot of Oct4 in adult wild type mice and Oct4GFP in 
adult transgenic mice from lung. 
Protein was isolated from whole lung homogenate of adult wild type mice and 
adult Oct4GFP transgenic mice respectively. (A) Oct4 detection shows a band 
size of 50 kDa (predicted molecular weight: 39-45 kDa). (B) Oct4-GFP shows 
a band size of 27 kDa (predicted molecular weight: 27 kDa). 
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3.7.2. Oct4 is expressed in perivascular and peribronchial spaces of adult mouse 
lung tissues and displays expression patterns like  telocyte localization 
The 3’3-diaminobenzinine (DAB) staining and immunofluorescence on paraffin 
embedded tissues sections were carried out to determine the location of Oct4. The two 
methods revealed the presence of Oct4 at the telocyte location in perivascular and 
peribronchial spaces (Fig. 25; Fig. 26). DAB staining gave a dark brown color. Oct4 was 
identified around the bronchus (Fig. 25A) and around the blood vessels (Fig. 25B). The 
immunofluorescence analysis using Oct4GFP transgenic mouse line showed that the cells 
expressing Oct4 displayed telocyte features. The showed long extensions called telopodes 
which seem to create contacts between two cells (Fig. 26). 
 
 
Fig. 25 Immunohistochemical staining of Oct4 in adult wild type mouse lung.  
Lung from adult wild type mice embedded in paraffin and stained with anti-Oct4. (A, B) the dark brown 
coloration marked with arrows and asterix represents Oct4 expression on DAB-labeled tissues. (A) The 
staining reveals the expression of Oct4 around the bronchiolar epithelium (black arrows). (B) Expression 
of Oct4 around the blood vessels (black asterix). Bar = 50 µm. 
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Fig. 26 Immunofluorescence staining of Oct4GFP transgenic mouse lung tissues. 
Oct4-GFP (green) is localized in the adventia of a blood vessel where the telocytes (Tc) are located. The 
cells present long extensions known as telopodes (Tp) which seem to create contacts between two cells. α-
SMA (red) labels the vascular smooth muscles located in the media. Nuclear stain DAPI (blue) Bar = 10 
µm. 
 
3.8. Oct4 positive cells display telocyte features in culture 
Oct4 positive cells were isolated based on GFP fluorescence. A small population which 
was EpCAMnegCD45negOct4-GFPpos was identified (Fig. 27). Dead cells were excluded 
with DAPI (Fig. 27A, panel 1), CD45-APC positive cells were excluded (Fig. 27B, panel 
1); EpCAM positive and EpCAM negative cells were analyzed (Fig. 27C). A small 
population of Oct4-GFP positive cells (EpCAMnegCD45negOct4-GFPpos) which 
represented 1.3 % was identified in the EpCAM negative cell fraction (Fig. 27D-F, panel 
2) and no Oct4-GFP positive population was detected in the EpCAM positive cell fraction 
(Fig. 27G-I, panel 3). Oct4-GFP positive cells were further sorted and kept in culture in 
normoxic conditions. After 5 days, the cells showed a fusiform shape resembling 
telocytes with one (Fig. 28A), two (Fig. 28B) or three (Fig. 28C) extensions. In addition, 
a cell with a monoliform extension was observed (Fig. 28C). The immunofluorescence 
staining of Oct4 positive cells showed that they were positive for vimentin (Fig. 28D), 
and negative for PDGFR-a (Fig. 28E). 
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Fig. 27 (Panel 1) Flow cytometric analyses of adult Oct4GFP transgenic mouse whole lung cell. 
Cells from adult Oct4-GFP transgenic mice were isolated and analyzed by flow cytometry. (A) Exclusion 
of dead cells. (B) Exclusion of CD45 expressing hematopoietic cells and gating of CD45 negative cells. 
(C) Setting of CD45 negative cells in two populations; EpCAM positive and EpCAM negative cells.  
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Fig. 27 (Panel 2) Flow cytometric analyses of adult Oct4GFP transgenic mouse whole lung cell. 
Cells from adult Oct4-GFP transgenic mice were isolated and analyzed by flow cytometry. (D) Getting 
of EpCAM negative cells. (E) Unstained cell as negative control. (F) GFP positive cells selected based 
on CD45negEpCAMnegGFPpos, represent 1.30 % of EpCAM negative cells. 
Section 3: Results 
60 
 
Fig. 27 (Panel 3) Flow cytometric analyses of adult Oct4GFP transgenic mouse whole lung cell. 
Cells from adult Oct4-GFP transgenic mice were isolated and analyzed by flow cytometry. (G) Gating of 
EpCAM positive cells. (H) Unstained cell as negative control. (I) EpCAM positive cells selected based 
on CD45negEpCAMposGFPpos do not contain GFP positive cells.  
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Fig. 28 Bright field visualization and immunofluorescence of 5 days cell culture of Oct4-GFP positive 
cells from transgenic mice sorted by FACS.  
GFP positive cells of Oct4-GFP transgenic adult mice were sorted and cultured for 5 days. 
Immunofluorescence was performed using Oct4 (green), vimentin (red), PDGFR-a (red) and DAPI (blue) 
antibodies. (A-C) Bright field images show cells with a fusiform telocyte- like shape with thin prolongations 
(telopodes: asterix). (A) Cell with one telopode. (B) Cell with two telopodes. (C) Cell with three telopodes. 
Note that the telopode has a particular shape resembling to a string of beads (arrows). (D) Co-expression 
of Oct4 and vimentin in telocytes. (E) Co-staining of Oct4 and PDGFR-a. PDGFR-a is not expressed in the 
cells. Bar = 50 µm. 
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3.9.  Oct4 positive cells express several telocyte markers in the perivascular 
compartment but not in the peribronchial compartment 
Immunofluorescence analyses carried out on paraffin-embedded tissues of adult wild type 
mice showed that Oct4 positive cells expressed several markers of telocytes including 
vimentin, C-kit, PDGFR-b, Sca-1 and VEGF. Oct4 co-localized with vimentin in both, 
the peribronchial space (Fig. 29) and in the adventitia of blood vessels (Fig. 30). While 
no co-expression of Oct4 with C-kit (Fig. 31), PDGFR-b (Fig. 32), Sca-1 (Fig. 33) and 
VEGF (Fig. 34) was observed in the peribronchial space, the co-localization with the 
same markers was observed in the adventitia of blood vessels (Fig. 35; 36; 37; 38). 
 
Fig. 29 Immunofluorescence of adult mouse lung bronchus against Oct4 and vimentin. 
Adult wild type lung tissues embedded in paraffin, and co-stained with Oct4 (green) and vimentin (red). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the bronchus. (B) Vimentin is 
expressed in the bronchus. (C) Co-localization of Oct4 and vimentin. Note that telopodes extend to the 
alveolar space (red arrows). . Bar = 10 µm. 
 
 
Fig. 30 Immunofluorescence of adult mouse lung blood vessels against Oct4 and vimentin. 
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Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and vimentin (red). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the blood vessels. (B), vimentin is 
expressed in the blood vessels. (C) Co-localization of Oct4 and vimentin (C). Bar = 10 µm. 
 
 
Fig. 31 Immunofluorescence of adult mouse lung bronchus against Oct4 and C-kit.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and C-kit (yellow). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive within the bronchus. (B) C-kit is expressed in 
bronchus. (C)  There is no co-localization of Oct4 and C-kit. α-SMA stains the smooth muscles lining the 
bronchiolar epithelium. Bar = 10 µm. 
 
 
Fig. 32 Immunofluorescence of adult mouse lung bronchus against Oct4 and PDGFR-b. 
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and PDGFR-b (yellow). 
DAPI (blue) was used as a nuclear stain. (A) Oct4 positive cells within the bronchus. (B) PDGFR-b is 
expressed in bronchus. (C) There is no co-localization of Oct4 and PDGR-b. α-SMA stains the smooth 
muscles lining the bronchiolar epithelium . Bar = 10 µm. 
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Fig. 33 Immunofluorescence of adult mouse lung bronchus against Oct4 and Sca-1.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and Sca-1 (yellow). 
DAPI (blue) was used as a nuclear stain. (A) Oct4 positive cells within the bronchus. (B) Sca-1 is expressed 
around the bronchus. (C) There is no co-localization of Oct4 and Sca-1. α-SMA stains the smooth muscles 
lining the bronchiolar epithelium . Bar = 10 µm. 
 
Fig. 34 Immunofluorescence of adult mouse lung bronchus against Oct4 and VEGF.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and VEGF (yellow).  
DAPI (blue) was used as a nuclear stain. (A) Oct4 positive cells within the bronchus. (B) VEGF is expressed 
in the bronchus. (C) There is no co-localization of Oct4 and VEGF. α-SMA stains the smooth muscles 
lining the bronchiolar epithelium . Bar = 10 µm. 
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Fig. 35 Immunofluorescence of adult mouse lung blood vessels against Oct4 and C-kit.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and C-kit (yellow). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the blood vessels. (B), C-kit is 
expressed in the blood vessels. (C) Co-localization of Oct4 and C-kit. α-SMA stains the smooth muscles 
expressed in the media . Bar = 10 µm. 
 
 
Fig. 36 Immunofluorescence of adult mouse lung blood vessels against Oct4 and PDGFR-b.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and PDGFR-b (yellow). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the blood vessels. (B) PDGFR-b is 
expressed in the blood vessels. (C) Co-localization of Oct4 and PDGFR-b. α-SMA stains the smooth 
muscles expressed in the media. Bar = 10 µm. 
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Fig. 37 Immunofluorescence of adult mouse lung blood vessels against Oct4 and Sca-1.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and Sca-1 (yellow). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the blood vessels. (B) Sca-1 is 
expressed in the blood vessels. (C) Co-localization of Oct4 and Sca-1. α-SMA stains the smooth muscles 
expressed in the media. Bar = 10 µm. 
 
 
Fig. 38 Immunofluorescence of adult mouse lung blood vessels against Oct4 and VEGF.  
Adult wild type lung tissues embedded in paraffin and co-stained with Oct4 (green) and VEGF (yellow). 
DAPI (blue) was used as nuclear stain. (A) Oct4 positive cells within the blood vessels. (B) VEGF is 
expressed in the blood vessels. (C) Co-localization of Oct4 and VEGF. α-SMA stains the smooth muscles 
expressed in the media. Bar = 10 µm. 
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3.10. Gene expression levels of telocyte markers in adult mouse lung tissues 
Single cell picking was done via laser capture microdissection (LCM) technique at the 
telocyte locations .After the dissection (Fig. 39A-39C), the cells were collected (Fig. 39D) 
and the RNA was isolated. Gene expression levels of telocyte markers were determined 
by real-time quantitative PCR. Levels of Oct4 expression were low in comparison with 
other tested markers and similar in vessels, bronchi, and septa. Vimentin, C-kit and Sca-
1 showed higher expression in vessels and septa compared to the bronchi. VEGF 
displayed highest expression in septa and levels of PDGFR-b expression were similar in 
the three compartments (Fig. 40). 
 
 
Fig. 39 Laser capture microdissection of adult wild type mouse lung cryosections.  
500 vessels, bronchi and septa of cryosection tissues of adult mouse lungs were microdissected and 
collected into different tubes. (A) Before the capture, the regions of interest (ROI) are circled. (B) During 
the capture, the laser cuts the ROI. (C) After capture, the ROI fall down into the cap of collecting tubes. 
(D) Dissected cells in the cap of the collection tubes.  
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Fig. 40 Gene expression levels of telocyte markers after cell picking by LCM. 
Gene expression levels of Oct4, vimentin, Sca-1, C-kit, VEGF and PDGR-b were determined by 
real time PCR.  Cells in telocytes location including the bronchi, blood vessels and septa were 
selected by laser capture microdissection (LCM) and RNA was isolated. Data are expressed in mean 
± SEM and n = 5 and the mRNA expression levels are shown as ΔCt values compared to GAPDH 
housekeeping gene control. 
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3.11.  Oct4 expression is deregulated upon naphthalene-induced lung injury in 
mice 
To determine whether Oct4 was regulated upon naphthalene treatment, its expression 
after injury was tested. The samples were collected at day 3, 7, 14 and 21 (these samples 
were kindly provided by Prof. Dr. Saverio Bellusci from the Excellence Cluster Cardio-
Pulmonary-System, Justus-Liebig-University, Giessen) and western blot analysis was 
performed (Fig. 41A). The expression Oct4 was significantly decreased from day 3 post-
injury until day 21 post-injury with 50 to 80 % of loss of expression (Fig. 41B). 
 
Fig. 41 Levels of Oct4 protein expression in adult wild type mice after naphthalene injury.  
(A) Expression of Oct4 protein detected by western blot at different time points after 
naphthalene treatment of adult wild type mice compared to corn oil treatment. (B) Histogram 
representation of relative density of Oct4 protein levels normalized to β-actin.  Naph 3d, 7d, 
14d and 21d: naphthalene at day 3, 7, 14 and day 21. n = 2 animals per group. Data are 
expressed in mean ± SEM. *p < 0.05; **p < 0.01. 
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SECTION 4: DISCUSSION 
4.1. BASCs play a role in lung regeneration but they are not necessarily the cells  
involved in the bronchiolar epithelium repair after naphthalene injury  
The primary purpose of this work was to characterize BASCs in adult mouse lung. BASCs 
were described first time in 2005 by Kim et al [12]. They reported that BASCs were cells 
showing stem cell characteristics and they were capable of regenerating the bronchiolar 
epithelium and the distal alveolar cells after naphthalene injury. Moreover, a role of BASCs 
in compensatory lung regrowth after PNX was as well described [101]. These findings on 
BASCs were highly argued among the scientific community. (i) The method used to isolate 
BASCs based on Sca1posCD34pos cell fraction was controversial as Sca1 is more 
representative of mesenchymal cell linages than epithelial cells [102]. (ii) The lineage 
tracing of BASCs did not show any evidence of BASCs of their role in lung repair [11]. In 
our study, first, we confirmed that BASCs were present at the BADJ based on their co-
expression for CCSP and SPC; their contribution in lung repair and regeneration after 
naphthalene and PNX was determined based on their proliferation activity. In fact, in the 
naphthalene model, we only observed the proliferation of BASCs at day 3 post-injury. 
Clara cells were still proliferating at day 6 until day 10 post-injury. In the study conducted 
by Kim et al [12], they reported that after naphthalene injury, the BASCs started to 
proliferate at day 2 post-injury and the proliferation was not observed yet in Clara cells; 
the Clara cells started to proliferate at day 3 post- injury. These data conformed to our 
observations and this suggests that BASCs may have a limited capacity of dividing 
compared to Clara cells. However, it is well known that in the process of repair in wounded 
skin for instance, the cells at the edge of the injury are stimulated and divide rapidly to 
generate new cells which are able to replace the damaged cells or tissues. When the repair 
is done, the cells will stop to divide [103]. It is therefore possible that the BADJ where 
BASCS reside and the region of neuroendocrine-associated Clara cells constitute two 
independent sites of injury. BASCs would then contribute to the repair at the BADJ part 
and Clara cells would repair the bronchiolar epithelium. Moreover, the BADJ and the 
neuroendocrine-associated Clara cells regions have already been described as reservoirs of 
stem cell niches. This further supports that the BADJ might be the region where the injury 
occurred first and then spread to the entire bronchiolar epithelium. Since the BADJ may 
heal first, the BASCs will then stop dividing first and the Clara cells will continue to divide 
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till the complete recovery of the bronchiolar epithelium. In fact, the theory of a pluripotent 
stem cell for all the areas of the adult lung has not been fully accepted. Based on a concept 
claiming that regional niches are present at different locations, they can therefore, control 
the phenotype and the expansion of the stem cells through the distinct  anatomical regions 
of the airways [3]. In the alveoli, some clusters of BASCs and Clara cells were also 
identified and the same observation was made. At day 6 post-injury, only Clara cells were 
still proliferating whereas BASCs had stopped to divide. The question remains if there is 
any significance of the presence of BASCs and Clara cells in alveolar space? If yes, is this 
aspect due to naphthalene treatment? Rawlins [11], identified in Scgb1a1-CreERTM; 
Rosa26R-eYFP adult mouse lung sections, many of the lineage-labeled type 2 cells at the 
vicinity of the BADJ expressing low levels of CCSP. However, it is interesting to see that 
in the naphthalene model, many BASCs and Clara cells organized in clusters were 
identified not only at the BADJ but also in alveolar space. Thus, it is possible that this 
appearance was correlated to the injury. Flow cytometric analyses strengthened this 
observation; a significant increase of BASCs and Clara cell populations at day 6 post-injury 
was detected. This may lead to the conclusion that; (i) naphthalene might not have only a 
toxic effect on bronchiolar Clara cells but also on alveolar cells and this can be the reason 
why some alveolar type 2 cells proliferated upon injury. (ii) It may be possible that BASCs 
present in alveolar tissues constitute a complete different cell population to the one present 
at the BADJ. Thus, BASCs would be like Clara cells, a heterogeneous population [104]; 
but their niche in the alveoli remain unknown. (iii) The BASCs in the alveolar space can 
also be derived from Clara cells since BASCs are also called variant Clara cells. However, 
although BASCs do express the CCSP Clara cell marker, there is no current evidence 
showing a correlation between Clara cells and BASCs cell types? From these observations, 
a lot of questions remain open about the cells or tissues which are impaired by naphthalene 
and which ones exactly contribute effectively to the repair in this model. Nevertheless, 
Clara cells seem to be the cells which actually contribute to the replacement of the depleted 
Clara cells. Besides, the question about the role of BASCs in adult mouse lung has not been 
yet elucidated. Moreover, our data don´t show a clear evidence of BASCs being the cells 
responsible for the bronchiolar epithelium repair. The effectiveness of BASCs as cells 
capable of repair and regeneration has been already proved in response to PNX in previous 
studies. It was shown in telomerase null mice , that the number of BASCs was reduced in 
the tissues compared to the wild type mouse tissue suggesting that BASCs play a role in 
lung regeneration [105]. We demonstrated in adult wild type mice that, at day 7 post-
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surgery, BASCs responded to PNX by proliferating, indicating BASCs as a functional stem 
cell pool required for the regeneration of adult lung tissues. In this study, our data 
demonstrated that although BASCs proliferated following PNX and naphthalene, these 
cells are not necessarily the cells responsible for the replacement of damaged Clara cells in 
the bronchiolar epithelium upon naphthalene injury in adult mouse lung.  
 
4.2. BASCs are a potential stem/progenitor cell type in adult mouse lung  
We provided the first evidence that BASCs are related to the EpCAMhighCD24low 
stem/progenitor cell fraction described by McQualter et al [70]. McQualter showed by real-
time PCR that the EpCAMhighCD24low cell fraction was enriched in CCSP-expressing Clara 
cells.  Moreover, the EpCAMhighCD24low cell fraction had a self-renewal capacity and also 
the ability to grow and generate different types of colonies including CCSP and SPC 
positive colonies. Our results confirmed these data but addition demonstrated for the first 
time that BASCs were also included in the EpCAMhighCD24low cell fraction. By 
immunocytochemistry of sorted ESPCs, we demonstrated for the first time that BASCs are 
EpCAMhighCD24low. By flow cytometry using the double fluorescent Cre reporter line 
CCSP-mCherry/SPC-YFP, we confirmed indeed, that CCSP positive cells alone 
represented 66 % of the EpCAMhighCD24low cell fraction. Moreover, BASCs which were 
less abundant were also included in EpCAMhighCD24low cell fraction. These data suggest 
that BASCs are potential stem/progenitor cells in adult mouse lung. Nevertheless, the 
question whether BASCs contribute to lung turnover, repair and regeneration in adult 
mouse lung remains still to be defined in various lung diseases models. These open 
question give rise to current debate if BASCs exist or not. Our data clearly demonstrated 
the evidence of cells expressing CCSP and SPC in the same cell at the BADJ and alveolar 
space. In addition, these cells also show the capacity to proliferate upon injury. Thus, our 
data might serve as a solid basis for further analysis elucidating the role of BASCS in 
pulmonary diseases and remodeling. 
 
4.3. Oct4 as a novel marker for the characterization of lung telocytes 
 The aim of the present study was to characterize and analyze BASCs function and their 
stemness activity. Therefore we traced Oct4 positive cells in adult mouse lung in order to 
elucidate if BASCs do express this marker of stemness. But the expression of Oct4 was not 
detected in BASCs. Surprisingly, Oct4 expression was restricted to a distinct cell type, the 
telocytes.  Moreover, based on flow cytometric analyses using Oct4-GFP transgenic mouse 
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line, Oct4 positive cells were not detected in the epithelial (EpCAMpos) cell fraction. The 
expression of Oct4 in adult tissues is a controversial topic in the field of adult stem cells 
research. The presence of Oct4 in adult tissue has been related to either PCR product 
artifacts, Oct4 pseudogenes or to other members of Oct family [77, 106, 107]. In the present 
study, we have demonstrated that Oct-4 was expressed in adult mouse lung tissues. But our 
data demonstrated Oct4 expression using transgenic mice and thus showed a reliable 
expression. In the present study, Oct4 positive cells were located in the peribronchial and 
perivascular spaces. Our data agree with recent the findings, that in the mouse pulmonary 
tissues telocytes are lining the blood vessels and the bronchi [108-110]. In the present 
study, we were able to isolate Oct4 positive cells and maintain them in culture. Oct4 
positive cells displayed in vitro similar structural features of telocytes which were already 
described in several studies of isolated telocytes from different organs [84, 111, 112]. In 
particular, we found similar numbers and the shape of telopodes furrowing and extending 
from Oct4 positive cells in accordance with those from Sca-1 telocytes [79]. Furthermore, 
we observed within the Oct4 positive cells, monoliform prolongations with thin cell body 
shape as also described for telocytes. Actually, telocytes are identified based on the number 
of their telopodes; with up to five telopodes with monoliform shape within, a succession 
of enlarged segments called podoms and thin segments called podomers [95, 113]. We 
identified also Oct4 in peripheral mononuclear blood cells but we did not focus on this cell 
type. They were discriminated during the isolation with anti-CD45 antibody and therefore, 
only the CD45negEpCAMnegOct4-GFPpos cell fraction was characterized. Moreover, the 
staining of Oct4-GFP positive after culture showed that they were all positive for vimentin 
and negative for PDGFR-a, a marker which is more representative of fibroblast cell 
lineages. Indeed, studies conducted on the gene expression profile of telocytes compared 
to fibroblasts in murine lung demonstrated that telocytes are not fibroblasts [114]. 
Numerous studies have demonstrated that telocytes have different ultrastructure and 
phenotype than fibroblasts [95, 115]. By immunofluorescence, we confirmed that Oct4 
positive cells share several markers with telocytes. They co-localized with several telocyte 
markers including C-kit, PDGFR-b, Sca-1 and VEGF [109, 116] in blood vessel 
compartment, whereas no co-localization was observed in the peribronchial space. These 
observations suggest that telocytes represent, at least immunophenotypically, a 
heterogenous cell type. The expression of the different above mentioned markers were 
confirmed on mRNA level by real-time PCR of the telocytes captured with laser 
microdissection from different locations including blood vessels, bronchi and the septa. It 
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is obvious that the mRNA levels of some markers including C-kit, Sca-1, PDGFR-b and 
VEGF do not fully concur with the immunohistochemical analyses. This especially applies 
to the peribronchial telocytes. However, it is possible that such a difference in the 
expression profile might be due to contamination with the adjacent cells which express 
different markers. In summary, we were able to show that Oct4 is expressed in adult mouse 
lung. We have demonstrated for the first time that Oct4 positive cells closely resemble the 
morphology of telocytes seen by electron microscopy. Thus Oct4 positive telocytes might 
represent a new candidate for stem cell function in the lung and might contribute to lung 
regeneration. In fact, Oct4 is well-known as a transcription factor and a stem cell marker 
and it is localized in the nucleus of ESCs. In our studies, western blot analysis revealed a 
band of 50 kDa which is 5 kDa bigger than the expected band size of Oct4 which expressed 
in the nuclear compartment of cells. This suggests that it might be a different isoform of 
Oct4 which is expressed in adult tissues. It is reported in the literature that human OCT4 
gene for example, can produce at least three transcripts by alternative splicing (Oct4A, 
Oct4B, and Oct4B1) and four protein isoforms (Oct4A, Oct4B-190, Oct4B-265, and 
Oct4B-164). Oct4A is expressed in nucleus and Oct4B is expressed in the cytoplasm. 
While it is well established that Oct4A is responsible for the pluripotency and the self-
renewal of ESCs, the function of Oct4B remains unclear. Studies suggested that Oct4B is 
involved in cell stress response [117-120]. Two different isoforms of Oct4 exist in mouse 
(Oct4A and Oct4B). Oct4A is the long isoform with an expected size of 39-45 kDa and the 
short isoform Oct4B, which may exist in the somatic tissues, has an expected size of 37 
kDa. In the present work, it seems that a completely different isoform may exist in adult 
mouse lung tissues and there are no current studies which report its expression in 
peribronchial and perivascular spaces. Therefore, the necessity for further studies of which 
Oct4 isoforms exactly are expressed in somatic tissues are required, and this may hence, 
challenge the role of Oct4 as a marker of pluripotency. As a matter of fact, in our study we 
were not able to show that Oct4 plays a role in lung repair. Its expression was 
downregulated after naphthalene injury suggesting that Oct4 is not also required for lung 
repair and regeneration of adult mouse lung tissues in response to naphthalene. But it might 
be different upper other disease models which has not been tested yet. However, these 
observations might also support the hypothesis that Oct4 might have other functions than 
to be a marker of pluripotency and its presence is not necessarily a hallmark of pluripotency 
[121]. Nevertheless, the function of Oct4 positive telocytes in different diseases contexts 
needs to be elucidated in the future. Since telocyte’s function might be very complex due 
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to their inter cell connecting properties. They might be a useful target for regenerative 
medicine. 
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SECTION 5: CONCLUSIONS-PERSPECTIVES 
   
5.1. Conclusions 
In conclusion, we showed for the first time that BASCs are related to the 
EpCAMhighCD24low ESPC cell fraction suggesting that they are a progenitor or a stem 
cell population in adult mouse lung. Even though we were able to demonstrate that 
BASCS may have a role in lung repair and regeneration after Clara cells damage because 
of their ability to proliferate, we were not able to provide the evidence that they are 
necessarily the cells which replenish the bronchiolar epithelium. But, we clearly 
demonstrated the presence of CCSP/SPC positive cells at the BADJ and in the alveolar 
compartment. Thus our study represents a solid basis for the existence of BASCs. Based 
on this, further studies are needed to analyze BASCs in different pulmonary disease and 
regeneration models. Following this line, we identified Oct4 positive telocytes as new 
possible candidates for lung regeneration and repair. 
 
5.2. Perspectives 
Further studies are clearly needed to elucidate BASCs in different disease and 
regenerative models. Distinct transgenic lineage tracing approaches have to be generated 
to trace BASCs in this context and to elucidate their differentiation capacity. Thus, their 
contribution to the regeneration of specific cell types might be clarified. The double 
fluorescent CCSP-mCherry/SPC-YFP transgenic mouse line which was used in the 
present study represents a useful tool for these analyses. Long term in vitro cell culture 
of BASCs is needed to test their ability to self-renew and differentiation. In vivo lung 
organoid assays may also be useful to test to test the contribution of BASCs to lung 
development. The generation of new transgenic approaches to trace and manipulate 
telocytes is necessary to give insights into telocyte function in disease and regeneration.  
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SUMMARY 
Bronchioalveolar stem cells (BASCs) have been shown to be a regional stem cell 
population in the distal lung. They are CCSP (Clara cell secretory protein) and SPC 
(surfactant protein C) positive. They respond to bronchiolar and alveolar injuries. BASCs 
are thought to maintain the bronchiolar Clara cells and the alveolar type 2 cells. Previous 
studies showed that Clara cells contribute to the renewal of the bronchiolar epithelium 
after oxidant mediated damages. Importantly, after the depletion of Clara cells through 
administration of naphthalene, residual cells of terminal bronchioles were fully capable 
of epithelial renewal and restoration.  These naphthalene-resistant Clara cells were 
present at the bronchioalveolar duct junction (BADJ). BASCs were isolated based on 
positive staining for CD34, a marker for skin epithelial cells and hematopoietic stem cells, 
and for Sca-1, a marker for stem cells. Others studies performed in adult mouse lung 
indicate that Sca-1pos cell fractions are predominantly representative of mesenchymal cell 
lineages. This highlights that Sca-1 is not a selectable marker for epithelial stem cells in 
the adult murine lung, and therefore the need of alternative functional assays for the 
identification and characterization of BASCs. In the present study, we characterized 
BACS by alternative methods. We identified by immunofluorescence the proposed 
BASC cell population co-expressing SPC, a marker for alveolar type 2 cells, and CCSP, 
a marker for bronchial epithelial Clara cells, that resides at the BADJ. BASCs were then 
identified by flow cytometry using double-fluorescent Cre reporter mice that express YFP 
and mCherry under the control of SPC and CCSP promoters; also based on an adjusted 
McQualter protocol for their expression of EpCAMhigh and CD24low. Clonogenic assays 
of EpCAMhigh and CD24low sorted cells cultured on feeders and matrigel showed BASCs 
as small colony-forming-units. The proliferative activity of BASCs after naphthalene 
injury and pneumonectomy was also determined. Based on their expression of 
EpCAMhigh-CD24low, we showed the evidence of BASCs as a potential progenitor/stem 
cells for distal murine lung. We further aim to establish in vivo differentiation assays for 
BASCs to address changes in stemness and proliferative activity during experimental 
lung disease and lung regeneration. 
Oct4, specifically expressed in embryonic stem cells, can also be detected in adult stem 
cells such as bone marrow-derived mesenchymal stem cells. A role for maintaining 
pluripotency and self-renewal of embryonic stem cells is ascribed to Oct4 as a 
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pluripotency marker. Several studies suggest a role for Oct-4 in sustaining self-renewal 
capacity of adult somatic stem cells. Other scientists have produced the evidence that Oct-
4 gene ablation in the somatic stem cells revealed no abnormalities in homeostasis or 
regenerative capacity. Data strongly argue that Oct-4, even if expressed at low levels in 
somatic cells, is dispensable for the self-renewal of somatic stem cells, for tissue 
homeostasis, and for the regeneration of tissue in the adult. The aim of this project was to 
trace Oct4 positive cells in adult mouse lung. We identified a distinct pulmonary Oct4 
expressing cell compartment that belongs based on its localization to telocytes. The 
hypothesis is supported from the literature reporting that telocytes are located in the 
perivascular wall and extended by their telopodes to the peribronchial and alveolar 
spaces. They express Oct-4, vimentin, Sca-1, PDGFR-b, C-kit and VEGF. We confirmed 
these results by immunofluorescence confoncal microscopy of adult wild type mouse 
lung. Flow cytometric analyses using Oct4-GFP reporter mice identified a population of 
Oct4-GFP positive cells. Oct4-GFP positive cells were sorted cultured and were growing 
with long extensions like telocytes.  Laser capture microdissection and qRT-PCR were 
also established to support immunofluorescence data on mRNA level. Since our data 
confirmed the hypothesis in which Oct4 positive cells are telocytes, our next goal is first 
to study the role of telocytes in adult mouse lung and determine the function of Oct4 in 
these cells. 
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ZUSAMMENFASSUNG  
Bronchioalveolare Stammzellen (bronchioalveolar stem cells, BASCs) wurden als eine 
regionale Stammzellpopulation in der distalen Lunge charakterisiert. Sie sind CCSP 
(Clara cell secretory protein) und SPC (surfactant protein C) positiv und reagieren bei 
bronchiolaren und alveolaren Verletzungen. Es wird vermutet, dass die BASCs den 
Bestand bronchiolarer Clara Zellen und der Alveolaren Typ II Zellen aufrechterhalten. 
Vorangegangene Studien haben gezeigt, dass Clara Zellen nach der Schädigung durch 
oxidativen Stress zur Erneuerung des bronchiolaren Epitheliums beitragen. 
Erwähnenswert ist, dass nach der Entfernung von Clara Zellen durch die Gabe von 
Naphtalen die verbliebenen Zellen im terminalen Bronchiolus in der Lage sind, das 
Epithel vollständig wiederherzustellen. Diese Naphtalen-resistenten Clara Zellen sind in 
den bronchioalveolaren Verbindungen, den sogenannten bronchioalveolar duct junctions 
(BADJ) lokalisiert. BASCs werden durch eine Positivfärbung für CD34, einem Marker 
für Hautepithelzellen und hämatopoetische Stammzellen sowie eine Positivfärbung für 
Sca-1, einem Marker für Stammzellen, identifiziert und isoliert. Andere in der Maus 
durchgeführte Studien deuten darauf hin, dass Sca-1pos Zellfraktionen überwiegend 
mesenchymale Zelllinien repräsentieren. Das wiederum zeigt, dass Sca-1 kein selektiver 
Marker für epitheliale Stammzellen in der adulten Mauslunge ist. Daher ist es notwendig, 
alternative funktionale Assays zur Identifizierung und Charakterisierung von BASCs zu 
etablieren. In der hier vorliegenden Studie werden die BASCs mit Alternativmethoden 
charakterisiert. Die durch die Koexpression von SP-C, dem Marker für alveolare Typ II 
Zellen, und CCSP, dem Marker für bronchiolare epitheliale Clara Zellen, definierte 
BASC Zellpopulation wurde mittels Immunofluoreszenz in den BADJ lokalisiert. 
Weiterhin wurden die BASCs mit Hilfe der Durchflusscytometrie (flow cytometry) 
identifiziert. Hierbei wurde eine Cre-Reportermauslinie verwendet, die eine 
Doppelfluoreszenz aus YFP und mCherry unter der Kontrolle der Promotoren für SPC 
und CCSP ausbildete, sowie ein angepasstes McQualter Protokoll für die Expression von 
EpCAMhigh and CD24low in BASCs. Klonogene Assays für diese auf EpCAMhigh and 
CD24low isolierten Zellen, die auf Futter-Zellen (Feeder) und Matrigel kultiviert wurden, 
zeigten BASCs als kleine, koloniebildende Einheiten. Die Proliferationsaktivität der 
BASCs nach einer Naphtalenbehandlung und Pneumonektomie wurde ebenfalls ermittelt. 
Basierend auf der EpCAMhigh and CD24low Expression in den BASCs konnte bewiesen 
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werden, dass diese Zellen potentielle Vorläufer/Stammzellen für die distale Mauslunge 
darstellen. Weiterhin soll ein in vivo Differenzierungs-Assay für BASCs etabliert werden, 
um die Veränderungen in der Stammzell- und Proliferationsaktivität während 
experimentell induzierter Lungenerkrankungen und Lungenregeneration zu untersuchen.  
 Oct4, das spezifisch in embryonalen Stammzellen exprimiert wird, kann ebenfalls in 
adulten Stammzellen detektiert werden, dort z. B. in mesenchymalen Stammzellen aus 
dem Knochenmark. Oct4 wird als Pluripotenz-Marker charakterisiert, wobei ihm eine 
Rolle in der Erhaltung von Pluripotenz und Selbsterneuerung embryonaler Stammzellen 
zugesprochen wird. Verschiedene Studien lassen vermuten, dass Oct4 zur Beibehaltung 
der Selbsterneuerungsfähigkeit adulter somatischer Stammzellen beiträgt. Andere 
Studien hingegen zeigen, dass eine Ausschaltung des Oct4 Gens in somatischen 
Stammzellen keine Anomalitäten in der Homöostase oder der Regenerationsfähigkeit 
dieser Zellen zur Folge hat. Einige Daten deuten sehr stark darauf hin, dass Oct4, auch 
wenn es in geringfügig in somatischen Zellen exprimiert wird, für die 
Selbsterneuerungsfähigkeit von somatischen Stammzellen, Gewebehomöostase und für 
die Regeneration von Gewebe in Adulten entbehrlich ist. Das Ziel dieses Projektes war 
die Detektion von Oct4 positiven Zellen in der adulten Mauslunge. Es konnte eine 
distinkte, Oct4 exprimierende Zellpopulation identifiziert werden, die auf Grund ihrer 
Lokalisation den Telozyten zugeordnet wurde. Diese Hypothese wird durch die Literatur 
gestützt, die Telozyten perivaskulär lokalisieren, wobei ihre Telopoden in den 
peribronchialen und alveolären Raum hineinreichen. Sie exprimieren Oct4, Vimentin, 
Sca-1, PDGFR-beta, C-kit und VEGF. Diese Resultate konnten in der Lunge adulter 
Wildtypmäuse mit Hilfe der konfokalen Mikroskopie durch Immunofluoreszenz bestätigt 
werden. Durch die Analyse mittels Durchflusszytometrie konnte auf der Basis von Oct4-
GFP Reportermäusen eine Population von Oct4-GFP positiven Zellen identifiziert 
werden. Diese Zellen wurden isoliert und kultiviert und zeigten ein charakteristisches 
Wachstum mit langen Extensionen wie bei Telozyten. Laser-Mikrodissektion und qRT-
PCR wurden etabliert um die Immunofluoreszenzdaten auf mRNA Ebene zu bestätigen.  
Da die Daten die Hypothese unterstreichen, dass es sich bei den Oct4-positiven Zellen 
um Telozyten handelt, ist das nächste Ziel, die Rolle der Telozyten in der adulten 
Mauslunge zu untersuchen und die Rolle von Oct4 in diesen Zellen zu ermitteln.  
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 APPENDICES 
Appendix 1: Oct4GFP transgenic mice genotyping 
 
 
Fig. 42 Genotyping of Oct4GFP transgenic mice. 
Transgene GFP, gene of interest = 173 bp and internal positive control = 
324 bp. The internal control primers typically amplify a genomic DNA 
region that is unrelated to your gene of interest. Successful amplification 
of the internal control indicates your DNA is suitable for PCR. 
   
Parameters  Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 
Temperature (°C) 94 94 60 72 72 10 
Minutes 1.5 0.5 1 1 1 ͚ 
Note  — 35 cycles 35 cycles 35 cycles —  
Table 11: Thermal cycling program of the PCR for the genotyping of Oct4GFP transgenic mice. 
Primers  Forward  Reverse  
GFP 5´-aagttcatctgcaccaccg-3´ 5´-tccttgaagaagatggtgcg-3´ 
Internal positive control 5´-ctaggccacagaattgaaagatct-3´ 5´-gtaggtggaaattctagcatcatcc-3´ 
Table 12: Primers used for the genotyping of Oct4GFP transgenic mice. 
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Components  Volume per reaction (µl) 
ddH2O 3.39 
10 X PCR buffer II (ABI) 1.20 
25 mM MgCl2 0.96 
2.5 mM dNTP 0.96 
GFP forward primer 0.6 
GFP reverse primer 0.6 
Internal  positive control forward primer 0.3 
Internal positive control reverse primer 0.3 
5 mMDNA loading dye 1.66 
5 U/µl Taq polymerase 0.03 
DNA template 2 
Table 13: Master mix per reaction of the PCR for the genotyping of Oct4GFP transgenic mice. 
 
Appendix 2: Oct4 staining vs. negative control in Oct4GFP transgenic mice 
 
Fig. 43 Expression of Oct4 in adult lung tissues compared to the negative control in transgenic mice. 
Alexa 488 was used for the negative control staining (A), and GFP-FITC was used for the positive staining 
(B). 
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Appendix 3: Oct4 staining vs. negative control in wild type mice 
 
Fig. 44 Expression of Oct4 in adult lung tissues compared to the negative control in wild type mice. 
(A), alexa488 was used for the negative control staining. (B), expression of Oct4 around a bronchus and 
(C), around a blood vessel using Oct4 antibody. 
 
Appendix 4: supplemental data of the laser capture microdissection 
The samples from vessels, bronchi and septa of Oct4 real-time PCR reaction after LCM 
were run on 1.5 % agarose gel. This was helpful for the analysis of the real-time PCR; 
the gel revealed single bands corresponding to the predicted amplicon length of 230-250 
bp. 
  
 
Fig. 45 Agarose gel of Oct4 real-time PCR reaction.  
(V1-V5) represents the 5 different samples of the vessel compartment used for the PCR; same was done 
for the bronchi (B1-B5) and for the septa (S1-S2). W (water) is the master mix reaction without the cDNA 
template.  The circles show bands with non-expected amplicon length probably due the quality of the RNA. 
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